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Globally, Endometrial Cancer (EC) is the sixth most common female cancer. 
Traditionally, EC is more common in high-income countries on account of the 
predominance of risk factors such as obesity and low parity. However, the 
epidemiological and health transition in South Africa (SA) after the advent of multi-
racial democracy in 1994 may impact EC trends in the country. We therefore evaluated 
the trends in EC from 1997 – 2015. 
Temporal trend analyses of the incidence and mortality of EC was conducted using 
the South African National Cancer Registry and the Statistics South Africa (Stats SA) 
data. Average annual percent change (AAPC) of the age standardised incidence rate 
(ASIR) and age standardised mortality rate (ASMR) rates were calculated using the 
Join point regression modelling to evaluate the incidence and mortality trends. Spatial 
distribution of ASMR of EC at province level was mapped using ArcGIS software. An 
unmatched case control study of the risk factors of EC was conducted using the Stats 
SA cancer mortality data. Statistically significant level was set at 95% confidence level 
(P-value: < 0.05). 
There were 14,238 cases and 3,955 deaths of EC over the study period. Incidence 
and mortality rates increased at 3.5% (95% Confidence interval (CI): 1.7-5.4, P-value: 
<0.001) and 3.7% (95% CI: 2.7-4.7, P-value: <0.001) per annum respectively. All nine 
provinces had increased ASMR with KwaZulu-Natal experiencing the highest AAPC 
of 8.2% (95% CI: 5.4-11.1, P-value: <0.001). Among the population groups, Blacks 
experienced the highest increase in ASIR with AAPC of 4.1% (95% CI: 2.0-6.3; P-
value: <0.001) while the increase in ASMR was highest among Whites16.3% (95% CI: 
8.4-24.7; P-value: <0.001). There was higher odds of EC deaths among the 
postmenopausal age group (adjusted odds ratio {adjOR}: 3.98; 95% CI: 3.14-5.03; P-
value: <0.001) and lower odds among divorcees (adjOR: 0.73; 95% CI: 0.59-0.89; P-
value 0.002) and smokers (adjOR: 0.53; 95% CI: 0.43-0.65; P-value: <0.001). 
In conclusion, there was an upward trend in incidence and mortality of EC in South 
Africa from 1997 – 2015. This reflects clearly in 8 of the 9 provinces with KZN 
experiencing the highest mortality. Public health interventions are necessary to reduce 
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This chapter focuses on the global burden of Endometrial Cancer (EC) and its trends 
among South African women. Literatures were reviewed on the current and future 
trends of EC, both in developed and less developed countries. Conclusion of this 
chapter culminates in the statement of the study objectives. 
1.1 Background 
Endometrial Cancer (EC) is a malignancy of the uterus that begins in the layer of cells 
that form the inner lining of the uterus. It is the sixth most common female malignancy 
globally, with varying regional incidence (International Agency for Research on 
Cancer, 2018). The regional differences in EC burden has been attributed to variations 
in prevalence of risk factors, preventive behaviours and healthcare system 
interventions (World Health Organisation (WHO), 2009).  
Several studies have demonstrated that EC rates are generally higher in high income 
countries (HIC) as opposed to that of the low and middle income countries (LMIC) (Lin 
et al., 2012; Torre et al., 2015; Lortet-Tieulent et al., 2017; Bray et al., 2018). Ferlay et 
al (2019) reported a global Age Standardised Incidence Rate (ASIR) for EC of 8.4 per 
100,000 women. However, there was wide regional disparity as the ASIR of EC was 
14.7 and 5.5 per 100,000 women in HIC and LMICs respectively. Furthermore, EC is 
the most common cancer of the female reproductive system in high income  countries, 
such as United States of America (USA) (Gizzo et al., 2014; National Cancer Institute, 
2016) while in South Africa, it is the second most common reproductive cancer, after  
cervical cancer (The Cancer Association of South Africa, 2018). 
The difference in regional incidence of EC may be attributed to a number of reasons: 
(1) higher prevalence of the risk factors of EC, such as obesity (Reeves et al. 2007; 
Bhaskaran et al. 2014) and diabetes, (2) differences in reproductive patterns such as 
early menarche, nulliparity (or low parity), delayed age at first child birth and use of 
hormone replacement therapy (HRT) (with unopposed oestrogen) (American Cancer 
Society, 2019). There is a higher prevalence of the aforementioned factors in high 
income countries. Due to westernization and urbanization, these factors are now 
increasingly being seen in LMIC, particularly those in sub-Saharan Africa (United 
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Nations, 2011; Nyirenda, 2016). Hence, the concept of the ‘double burden of 
communicable and non-communicable disease’ (NCD) is evident in LMICs. This is 
because LMICs now have increased prevalence of NCDs (including cancers) (Iyoke 
and Ugwu, 2013), with the background  burden of infectious disease (Maher, Smeeth 
and Sekajugo, 2010). 
The republic of South Africa is a multi-racial, upper middle income country that is 
currently undergoing epidemiological and demographic transition (National Research 
Council, 2012). The resulting health transition may have an effect on the pattern, 
incidence and mortality of EC in the nation. However, little evidence exists on the 
current EC trends in South Africa to inform public health interventions. 
1.2 Problem Statement 
Despite being a potentially curable disease, EC appears to be increasing globally 
(Fader et al., 2009). Some LMICs with rapid socioeconomic transitions contributed a 
higher proportion of the increase in the global EC incidence and mortality (Onstad, 
Schmandt and Lu, 2016; Lortet-Tieulent et al., 2017). Bray et al has posited an 
increase of 60% in the incidence of cancer by the year 2030, in LMICs.  
The World Health Organisation (WHO) recommends a national cancer-control 
programme for countries to achieve cancer prevention and control. A key component 
of the strategy is accurate cancer surveillance to influence efficient resourcing 
mechanism (Duncan et al., 2019). Gynaecological cancers have gained some 
attention in South Africa cancer control policy, however, more active utilization of 
available data on various cancers is needed to prioritize focus.  
Presently, there is no evidence of the EC trends and predictors of EC mortality in South 
Africa, a country with rapid health and epidemiological transition. The few studies 
available on EC in South Africa have are hospital-based studies (Branch, 2016) or 
restricted to a particular age group (Ray et al., 2019). These will have limited inferential 
value on the national indices. 
1.3 Justification of Study 
As health policies and socially-inclusive polices to eradicate inequalities are being 
developed in post-apartheid era of South Africa, there are changes in the 
socioeconomic status of women. The resultant health transition could impact EC 
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trends in the country (The Stellenbosch Institute for Advanced Study, 2020). There is 
an increasing trend in the prevalence of obesity in South Africa (Sartorius et al., 2015). 
Furthermore, low parity is getting common among South African women (Burger, 
Burger and Rossouw, 2012). Thus, EC trends may increase in South Africa. 
It is imperative to provide evidence of the trends in EC mortality and morbidity in South 
Africa so as to be able to highlight the needs for interventions, and possibly 
demonstrate the impact of previous health system policies on the evolution of EC in 
the country. The study can also raise awareness about a disease that is potentially 
curable. Information obtained from this study will be useful in future assessment of 
reproductive health policies, thereby aiding informed decision-making process.  
Cervical cancer control program has enjoyed more attention compared to other  
female gynaecological cancers, with a clearly stated National Cervical Cancer 
Prevention and Control policy (National Department of Health, 2017). Such 
documentation does not exist for the prevention and control of EC.  
This study therefore describes the trend, distribution and predictors of EC in South 
Africa with a view to providing information to guide the formulation of the correct policy 
for interventions. 
1.4 Literature Review 
1.4.1 Pathology of Endometrial Cancer 
EC is a malignancy arising from the endometrial lining of the uterus (see Figure 1.1). 
It is also called cancer of the corpus uteri (Scully, 2003; Lindemann et al., 2015; 
American Cancer Society, 2016). In the 10th Revision of the International Statistical 
Classification of Diseases and Related Health Problems (ICD-10), EC is coded as C54 
and classified as ‘malignant neoplasm of the corpus uteri’ (WHO, 2016).  
The endometrium is the inner lining of the uterus. Throughout the reproductive years, 
the endometrium goes through cyclical histological changes within the menstrual cycle 
(Botha, 2009). Trophic hormones are responsible for the stimulation of the 
endometrium during each cycle. As a result, the endometrium undergoes normal 
growth during different cyclical phases that eventually culminates in the secretory 
phase. Oestrogen and progesterone are the two hormones that regulate the 
endometrial cycle (Kumar, Abbas and Aster, 2014).  
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Figure 1.1: Female reproductive organs with Endometrial Cancer in the womb lining. 
Picture credit: (Medscape, 2015) 
During the menstrual cycle there is an elaboration of oestrogen. This causes growth 
and increases the thickness of the endometrium (known as the proliferative phase). 
The excessive production of oestrogen results in hyper stimulation of the endometrial 
stratum functionalis. On the other hand, progesterone causes the “luteinisation”, mucin 
secretion (secretory phase) and eventual shedding of the endometrium. If 
progesterone is not elaborated, the secretory phase of the menstrual cycle will be 
hampered, thereby preventing endometrium shedding. The eventual hyperplastic 
endometrium may undergo malignant changes leading to occurrence of EC (Kumar, 
Abbas & Aster, 2014). 
In 1983, Bokhman (1983) classified EC into two (Dualistic model) based on their 
histological, clinical and metabolic presentations: The two types EC are: 
a) Type I EC: Type I EC is an oestrogen-dependent, low grade tumour commonly 
related to hyperplastic proliferation of the endometrial glands. Generally, Type 
I EC is symptomatic in the early stages (Weiderpass et al., 2014; Muhammad 
et al., 2017), making early presentation at the hospital possible. Type I EC, 
therefore, has the potential for early diagnosis and prompt treatment, with good 
prognosis after appropriate treatment (Weiderpass et al., 2014; Muhammad et 
al., 2017). Type I EC accounts for about 75-80% of EC cases (Stewart and 
Wild, 2014; Sanderson et al., 2017). The Type I EC is more common among 
obese, diabetic, nulliparous, non-white, late menopausal women, and women 
with Polycystic Ovarian Syndrome (PCOS) (Feinberg et al., 2019). 
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b) Type II – This type of EC is an oestrogen-independent, more clinically 
aggressive tumour that is usually associated with atrophic endometrium of 
postmenopausal women. Type II EC has worse prognosis as it has a high 
tendency for metastasis (Bokhman, 1983; Matias-Guiu and Prat, 2013).  
This ‘dualistic’ classification system has been identified as being too simplistic. This is 
because it does not account for some other variants of EC. However, it is in popular 
use and still remains a good conceptual framework to understand the pathogenesis of 
EC (Talhouk and McAlpine, 2016).  
1.4.2 Histological classification of Endometrial Cancer 
Broadly, cancers arising from epithelial cells found in the tissue that line internal organs 
are known as carcinomas while those arising from the mesenchymal cells found in the 
connective tissue such as the muscle are known as sarcomas.  
The four major histological types of EC and their International Classification of 
Diseases for Oncology, third edition (ICD-O-3) morphology codes include 
endometrioid adenocarcinoma (8380/3), mucinous adenocarcinoma (8480/3), serous 
adenocarcinoma (8441/3) and clear cell carcinoma (8310/3). Other types include the 
mixed adenocarcinoma (8323/3), squamous cell carcinoma (8070/3), transitional 
carcinoma (8120/3), small cell carcinoma (8041/3), and undifferentiated carcinoma 
(8020/3) (Scully, 2003). Type I (of the dualistic model classification) is usually of the 
endometrioid adenocarcinoma histology type while Type II is usually serous and clear 
cell carcinoma (Wright et al., 2012; Setiawan et al., 2013). The endometrioid 
adenocarcinoma is the most common and consists of the variants- adenocarcinoma 
with squamous differentiation (8570/3), villoglandular (8262/3), secretory (8382/3), 
and ciliated cell variant (8383/3) (R. Scully, 2003). 
1.4.3 Risk factors for Endometrial Cancer 
The risk factors for EC can either be:  
a) Non-Genetic or modifiable risk factors and  
b) Genetic factors. 
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The non-genetic or modifiable risk factors are advanced age and conditions that 
generally lead to endogenous exposure to excessive oestrogen. Exogenous exposure 
to unopposed oestrogen also constitutes a non-genetic risk factor (Morice et al., 2016). 
Strong genetic factors are suspected based on the history of a first degree relative 
having EC or colorectal cancer. (Win, Reece and Ryan, 2015) . 
Obesity is a major risk factor that is classified as a non-genetic risk factor but may 
have some genetic basis (Choquet and Meyre, 2011). 
Age 
As with most cancers, increasing age is a risk factor for EC. The peak age of incidence 
of EC is in the sixth and seventh decades of life. A meta-analysis on EC reported the 
mean age of incidence of EC as 63 years (Collaborative Group on Epidemiological 
Studies on Endometrial Cancer, 2015). Post-apartheid era has led to increased access 
to reproductive healthcare (Ndinda et al., 2018) among the majority black population 
in South Africa. Thus, there is increasing longevity as the average life expectancy of a 
South African woman increased from 61.6 years in 2000 (Statistics South Africa, 2010) 
to 71.6 years in 2016 (Statistics South Africa, 2017b). This may increase the incidence 
and mortality from EC among the older South African women. 
Endogenous exposure to excessive oestrogen 
Endogenous exposure to excessive oestrogen includes factors that naturally increase 
the exposure to oestrogen. Such factors are menstruation-related, reproductive 
system-related factors and high body adiposity levels. The latter is seen in overweight 
and obese individuals (American Cancer Society, 2019). 
Menstruation-related factors such as early menarche (menstruation onset before age 
12 years) or late natural menopause (menopause at age >55 years) increases the risk 
of EC (American Cancer Society, 2019). Additionally, reproductive system-related 
factors such as nulliparity or infertility increases the EC risk (Wu et al., 2015). 
Advanced age at last birth (>35 years at last delivery) is however a protective factor 
against EC (Parazzini et al., 1991; Setiawan et al., 2012). 
There is an association between body adiposity level (Obesity)and EC (Arnold et al., 
2015). Overweight and obese women had about a 2 to 3.5 fold increased risk of EC 
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(Kitson and Crosbie, 2019). Also, 40% of EC cases have been linked to obesity 
(Onstad, Schmandt and Lu, 2016). Obese women have higher levels of endogenous 
oestrogen due to the conversion of androgen to oestradiol in the peripheral adipose 
tissue (Kumar, Abbas and Aster, 2014). At the 2016 world obesity day, 70% of South 
African women were said to be overweight or obese (National Department of Health 
South Africa, 2016). Thus, increasing obesity among South African women may fuel 
an increasing trend in EC incidence in the country. 
Exogenous exposure to oestrogen  
In some cases, the high level of circulating oestrogen is secondary to ingestion of 
drugs medications used for hormone replacement therapy (HRT) and Tamoxifen. 
HRTs are prescribed to women who are perimenopausal or menopausal to alleviate 
menopausal symptoms. The ‘unopposed oestrogen’ type of these pills has been 
shown to increase the risk of developing EC (Sjögren, Mørch and Løkkegaard, 2016). 
According to a systematic review by Sjogren and colleagues, unopposed oestrogen, 
sequential combined therapy, and tibolone all increase the risk of EC (Sjögren, Mørch 
and Løkkegaard, 2016). However, these researchers reported that ‘continuous 
combined oestrogen’ therapy use reduce the risk of EC. 
Tamoxifen is an anti-steroidal oestradiol inhibitor used in the treatment, and 
sometimes prevention, of some cases of breast cancer (Vanderpuye et al., 2017). 
Studies have shown that patients who were prescribed and used Tamoxifen for up to 
5 years had about 1% increased risk of developing EC. Such prolonged Tamoxifen 
users have been noted to develop the more aggressive Type II EC, with a worse 
prognosis (Jones et al., 2012). 
Endometrial Cancer and Human Immunodeficiency Virus 
Human Immunodeficiency Virus (HIV) infection is a major public health concern in 
South Africa. This is because the country has the highest absolute number of infected 
people globally (AVERT, 2018; GDB 2017 HIV collaborators, 2019). There are 
conflicting reports of the role of HIV on the evolution of EC. While Goedert et al, found 
that the incidence of EC was lower among women living with HIV/AIDS as compared 
with the general population (Goedert et al., 2006), a recent systematic review reported 
similar incidence of EC in the general population and among HIV positive women 
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(Smith et al., 2019). Nonetheless, it is important to evaluate the effects of the changing 
HIV prevalence and antiretroviral therapy on the burden of EC in South Africa. 
Genetics 
EC is characterized by the mutation and or deletion in the Phosphatase and Tensin 
Homolog (PTEN) and Tumour Protein p53 (TP53) tumour suppressor pathways, for 
the Type I (Mutter et al., 2001) and Type II EC respectively. The effect of the change 
on PTEN is modulated by the hormonal (oestrogen) milieu of the body. The PTEN is 
a negative regulator of cell growth and survival (Murali, Soslow and Weigelt, 2014). A 
change in PTEN gene may lead to an abnormal growth of the endometrial lining. 
The Lynch Syndrome (LS) – an inherited genetic syndrome in which there is loss of 
one of the DNA mismatch repair (MMR) genes, resulting in DNA replication errors – is 
associated with the occurrence of EC and colorectal cancer (Cook et al., 2014; Centers 
for Disease Control and Prevention, 2020). Non-LS EC patients also exist. This 
provides some evidence of the existence of an EC-specific genetic syndrome pathway, 
apart from the MMR defect resulting from the LS. 
Another multi familial genetic predilection is the Cowden Syndrome. This results from 
germline mutations in the PTEN gene. Cowden Syndrome is an autosomal dominant 
disorder and patients have a high risk of breast, uterine and non-medullary thyroid 
cancer (National Institute of Health, 2020). 
1.4.4 Prevention of Endometrial Cancer 
According to the World Health Organization (WHO), 30 – 50% of cancers are 
preventable (World Health Organisation, 2018). There are different levels of public 
health prevention of cancers. These are primordial, primary, secondary, tertiary and 
quaternary levels of prevention (Pandve, 2014). 
Prevention policies of EC are currently hinged on increasing public awareness of the 
disease, reducing the exposure to, or reducing the prevalence of, risk factors. 
Treatment policies are currently focused on early diagnosis and surgical intervention 
(secondary prevention), usually in the form of hysterectomy (Council for Medical 
Schemes, 2019).  
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EC is usually symptomatic in the early stage of the disease, particularly in the Type I 
EC (endometrioid adenocarcinoma). Additionally, EC has low rates of metastasis. 
Hence, early presentation to the hospital, prompt diagnosis and subsequent 
appropriate treatment allows for the relatively high five-year survival rate of 70% - 90% 
(American Cancer Society, 2018). 
The ascertainment of EC starts from a clinical interview with a female patient with 
history of abnormal uterine bleeding commonly occurring as post-menopausal 
bleeding. It could also be a history of heavy menses or intermenstrual bleeding in the 
pre-menopausal age group. Pelvic or transvaginal ultrasound scan is done to measure 
endometrial thickness. If the endometrial thickness is 5mm or more (in a non-pregnant 
uterus) then endometrial sampling is carried out to have endometrial lining biopsied 
for histological evaluation. The diagnosis of a primary endometrial cancer is largely 
confirmed by ultrasonography and then endometrial sampling for histological report 
(Decherney et al., 2019). 
Screening opportunity for EC is limited as there are no precursor lesions with a window 
period of intervention as seen in cervical cancer (Costas et al., 2019). However, 
researchers  proposed some screening activities that may be adopted (Kitson, Gareth 
Evans and Crosbie, 2017). An EC risk prediction score was calculated from 4 
parameters viz: Genetic, Insulin, Reproductive and Obesity score. Kitson et al 
therefore proposed to divide post-menopausal women into low, medium and high-risk 
categories. The possible score ranges will be used for risk stratification and dictate 
health advice and prophylactic measures to be taken. This, and other prediction 
models, however need further validation (Alblas et al., 2018). 
Currently, the most popular method used in the prevention of EC is secondary 
prevention, which involves early diagnosis of the disease and appropriate early health 
seeking habits (American Cancer Society, 2020). Since 90% of affected women have 
symptoms in form of post-menopausal bleeding even at the early stages of the 
disease, it makes early presentation in the hospital a viable means of reducing 
mortality from EC. However, patients and healthcare providers must be aware of the 
risk factors and early symptoms so as to prevent delay in diagnosis. Therefore, the 




1.4.5 Survival pattern of Endometrial Cancer 
The five-year survival rate of EC is good. Siegel et al (2013) estimated that about 16% 
of new cases of advance-staged EC in the USA resulted in death within five years. 
Survival patterns vary across countries, with the HIC having lower mortality rates 
relative to their corresponding incidence rate as shown in Table 1.1. 












8.3 14.7 5.5 6.5 3.5 
Estimated 
Mortality  
1.8 2.3 1.5 1.8 1.3 
 
A larger proportion of the incident EC cases results in death in the Southern African 
region. Than in any other part of the world (Ferlay et al., 2019). 
Mortality-to-incidence ratio (MIR) is a population-based indicator or crude surrogate of 
survival (Asadzadeh Vostakolaei et al., 2011). MIR helps to understand how the 
impact of a disease has changed over time (Ellis et al., 2014). Several studies have 
demonstrated that the MIR is a practical tool for evaluating the five-year survival rate 
of different cancers (Choi et al., 2017; Stenning-persivale et al., 2018). A high MIR has 
been shown to be reflective of a poor health system ranking (Sunkara and Hebert, 
2015).The lower the MIR, the higher the MIR complement (1-MIR x 100%). A high MIR 
complement suggests a high five-year survival rate while a low MIR complement 
suggests a low five-year survival rate (Stenning-persivale et al., 2018). 
Bray et al. showed that 37% of incident cases of EC in Southern Africa will result in 
death (Bray et al., 2018). However, despite the relatively higher incidence in ‘more 
developed regions’ such as the United States of America, only about 15% of incident 
cases result in death (Siegel, Naishadham and Jemal, 2013; Ferlay et al., 2015).  
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1.4.6 Conceptual framework of the study 
Several theoretical models underpin various public health and social science studies 
and interventions (Petrini, 2010). Among such models are the social ecological model, 
the health belief model and the social cognitive theory (Sallis, Owen and Fisher, 2008). 
This present study postulates that disease incidence and health outcomes (mortality 
or survival) in individuals are determined by factors at multiple levels – intrapersonal, 
interpersonal, community and societal – all of which are interrelated and are relevant 
for proffering targeted appropriate public health interventions. This is the concept of 
the socioecological model (SEM) approach to disease evolution in public health 
(Mcleroy et al., 1988; Koh et al., 2010). The SEM was first introduced by Mcleroy et al 
in 1988 and has since been adopted as one of the theoretical framework for studying 
various diseases, including EC (Milne et al., 2011). 
Thus, using the SEM approach, a four-level model as shown in Figure 1.2, was 
proposed for the present study based on available data and literature reviews. 
‘Intrapersonal factors’ (such as age, menopausal status, educational status, smoking 
status) are intrinsic to an individual.  These intrapersonal factors can sometimes be 
determined by, and also impact upon, ‘Interpersonal factors’ (such as reproductive 
pattern, health seeking behaviour and family structure). All these happen within the 
context of the societal values and the level of development of the society or province, 
whether urban or rural, (third level), and are shaped by ‘Macro policies’ (fourth level), 
such as the public health system policy (such as National Health Development Plan, 
Tobacco Control Act), economic and educational policies, including access to 
reproductive health services.  
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Figure 1.2: Conceptual framework for factors associated with EC 
(Adapted from Mcleroy et al., 1988) 
The first and second levels are the proximal or downstream factors a woman has a 
level of control over while the third and fourth levels are the distal or upstream factors 
which are mostly the purview of the government and policy makers to build a health-
enhancing country. 
1.5 Research Question 
What are the patterns of distribution and predictors of the Endometrial Cancer rates in 
South Africa from 1997 to 2015? 
1.6 Research Hypothesis 
The following are the hypotheses proposed: 
Null Hypothesis 1: There was no change in EC incidence, mortality and MIR from 
1997 to 2015 in South Africa. 
Alternative Hypothesis 1: There was a change in EC incidence, mortality and MIR 
from 1997 to 2015 in South Africa. 
Null Hypothesis 2: There was no change in the pattern of distribution and predictors 
of the EC rates from 1997 to 2015 in South Africa. 
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 - social protection 
 
 Societal 
• Rural/ Urban 
• Cultural preferences 
• Level of development  
 Interpersonal 
• Health-seeking behaviour 
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13 
Alternate Hypothesis 2: There was a change in the pattern of distribution and 
predictors of the EC rates from 1997 to 2015 in South Africa. 
1.7 Research Objectives 
Aim 
This study aimed to evaluate the trends, distribution and predictors of EC rates in 
South Africa from 1997 to 2015. 
Specific Objectives 
The specific objectives of the study were: 
1. To determine the trends in the incidence rate of EC in South Africa from 1997 
to 2014  
2. To determine the trends in the mortality rates of EC in South Africa from 1997 
to 2015 
3. To describe and map the spatial distribution of EC deaths in South Africa, by 
province of usual residence from 1997 to 2015. 
4. To describe the difference between EC death group and non-EC death group, 




2.1 Chapter Overview 
This chapter gave a description of the study settings, study design and sampling 
methods of this study. Data management and the statistical analyses that were 
conducted are also discussed. 
2.2 The Setting of the Study 
2.2.1 The South African Demography 
South Africa is a middle income country whose population is multi-racial due to its 
unique history (Mosala, Venter and Bain, 2017; Wright, 2019). It is the 25th most 
populous nation in the world with a population of 55.91 million in 2016. The proportion 
of females in the country was 51% in 2016. There are four major population groups 
namely Africans/Blacks, Whites, Indians/Asians, Coloureds (mixed ancestry) : 80.6%, 
8.1%, 2.4% and 8.9% respectively (Statistics South Africa, 2017a) as shown in Figure 
2.1.  
 
Figure 2.1: Population groups in South Africa (Statistics South Africa, 2017b) 
The life expectancy at birth in 2016 was 66 years among females (Statista, 2020). 
Although there has been a steady rise in the annual growth rate of people older than 
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60 years, they constitute about 8% of the population. The population structure of South 
Africa is as depicted in the Figure 2.2. 
 
Figure 2.2: The population structure of South Africa in 2016 (Statistics South Africa, 
2017b) 
The country is divided administratively into nine provinces namely; Eastern Cape, Free 
State, Gauteng, KwaZulu-Natal, Limpopo, Mpumalanga, North West, Northern Cape, 
and Western Cape. The Northern cape is the least populated province (though the 
largest in landmass) while Gauteng is the most populated province and has the 
smallest landmass (Government of South Africa, 2018). 
2.2.2 Study Design 
The study is a temporal trends and secondary data analyses. The study is also a case 
control study of EC and non-EC mortality. Deaths from EC that were administratively 
collected by Statistics South Africa (Stats SA) and incident cases of histologically-
confirmed EC from the National Cancer Registry (NCR) were analysed. Thus, EC 
incidence data, obtained from NCR from 1997 to 2014 (18-year period), and mortality 
data for EC, obtained from Stats SA between 1997 and 2015 (19-year period), were 
analysed.  
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An unmatched case control study was also designed from the Stats SA data to 
evaluate possible risk factors of EC mortality. The cases were the EC deaths and the 
controls were other female cancer deaths. Female cancers that were related to EC 
such as colorectal cancer, breast cancer and other gynaecological cancers were 
excluded from the control arm of the study (Table 2.1). 
Table 2.1: Cancers excluded from the control arm of the study 
Major Factors 
associated with EC 
Cancers 
Obesity Breast, Meningioma, Thyroid, Adenocarcinoma of the 
Oesophagus, multiple Myeloma, Liver, Kidney, Stomach, 
Pancreas, Gall bladder, Colon, Rectum, Ovary. 
Hormonal and 
reproductive factor 
Breast, Biliary, Bile duct, Placenta, Other Gynaecological 
cancers- Vulvar, Vagina, Cervical, Fallopian tubes, Ovary  
Lynch Syndrome Colorectal, Ovary 
HIV Conjunctiva, Nasal, Oral, Oesophageal, Kaposi sarcoma, 
Larynx, Lung, Non-Hodgkin’s lymphoma, Leukaemia, 
Stomach, Cervix, Vagina, Vulvar,  
Smoking Lung, Leukaemia, Larynx, Oral cavity and throat, 
Oesophagus, Stomach, Colorectal, Pancreas, Liver, 
Ovary, Cervix, Breast, Leukaemia 
 
2.2.3 Data Sources 
The data sources were both Statistics South Africa and National Cancer Registry. The 
data utilized were those available at the commencement of the study. 
Statistics South Africa 
The Stats SA routinely collects mortality data for the country by reviewing the mortality 
data as supplied to the Department of Home Affairs (Statistics South Africa, 2016). 
This national organization also conducts periodic population census exercises. Stats 
SA produces the annual mid-year overall population estimates by population group 
and province. Information about the age at death, date of death, cause of death, 
ethnicity, smoking history, province of usual residence, marital status, educational 
qualification and occupation/industry of the deceased (Statistics South Africa, 2016) 
are also available. Datasets for this study were made available on request. 
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The ‘Underlying cause of death’ was entered according to the Tenth Revision of the 
International Statistical Classification of Diseases and Related Health Problems (ICD-
10) code of the disease. All deaths caused by code C54, which represents uterine 
cancers, made up the dataset. 
National Cancer Registry 
The NCR collects histologically confirmed cancer cases from all the laboratories (both 
private and public) in South Africa. The registry was established in 1986 and reporting 
of cancer cases by laboratories was initially voluntary. Hence, some cases were not 
reported, especially from private laboratories (Singh, Underwood, et al., 2016). In 
2011, more legislative power was given to the NCR by the Government of South Africa, 
making it mandatory for all laboratories to report cancer cases to the NCR in order to 
improve the documentation on cancers (National Cancer Registry, 2017).  
Coding of cases by the NCR is based on the third edition of International Classification 
of Diseases for Oncology (ICD-O-3). Datasets obtained on request from the NCR for 
this study included the ICD-O-3 topographic code C54, which includes C54.0-C54.3, 
C54.8 and C54.9, and the topographic code C55.9.  
To compare incidence data with the mortality data, only C54 is directly equivalent to 
International Classification of diseases ICD-10 code C54, C55.9 was therefore 
excluded (see Figure 2.3) as C55.9 which stands for Corpus uteri Not Otherwise 
Specified (NOS) was also not captured in the mortality data. NCR collects data on age 
and population group of the patients. Hot deck imputation technique was used by the 
registry to handle missing data in population group (Singh, Underwood, et al., 2016). 
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Figure 2.3: Data exclusion for incidence Endometrial Cancer data from NCR 
2.2.4 Target Population 
The target population for the trends analysis of the incidence and mortality of EC was 
the total female population of South Africa. The dataset used for the study are 
nationally representative as Stats SA receives data of death notifications from all the 
provinces in the nation through the Department of Home Affairs. All histologically-
diagnosed cancers in both hospitals and all private laboratories are reported to the 
NCR. 
Trends and spatial distribution arm of the study 
Study population 
All newly diagnosed cases of EC from 1997 to 2014 in the NCR records were included 
in the study population for the incidence trends analysis. Women whose underlying 
cause of death was EC as stated by the death notification forms sent to Stats SA from 
the hospitals and communities for the 19-year study period (1997- 2015) were the 
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EC incident cases – ICD-O-3, code 54 (to include C54.1, C54.2, C54.3, C54.8 and 
C54.9).  
Mortality from EC – underlying cause of death: ICD-10, code C54. 
Independent variables 
The explanatory variables were: 
Incidence data: year of diagnosis, age at diagnosis, population group and histological 
type of EC. 
Mortality Data: year of death, age at death, population group, province of usual 
residence, marital status, smoking history, and formal school attainment of the 
deceased. 
Case control arm of the study 
The purpose of this arm of the study was to identify some predictors of mortality from 
EC among South African women. The study population was all females who died 
within the study period (1997 to 2015) with underlying cause of death being cancer or 
malignancy (ICD 10, C00 – D48). Included cases were all EC deaths, while the 
controls included all females who died as a result of a malignancy other than EC.  
In order to improve the reliability of the level of associations obtained from the 
statistical tests, cancers that could confound the study were excluded.  
Cancers that were excluded from the control arms include cancers that share 
etiological factors with EC occurrence. Such cancers were divided into five main 
categories based on the major factors associated with EC (either as a risk factor or 
protective factor). Obesity, hormonal and reproductive factors as well as Lynch 
syndrome are risk factors while HIV and smoking seem to be protective factors as 
reported by studies (Goedert et al., 2006; Oliver and Chiao, 2017). (See Table 2.1). 
The list of excluded cancers was based on literatures and the International Agency for 
Research on Cancer (IARC) monograph(International Agency for Research on 
Cancer, 2020).  
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2.3 Data Management 
2.3.1 Data quality control 
The NCR and Stats SA provided Excel spreadsheets of datasets with anonymized 
data. These were organized using the Excel software to get clearly defined output 
according to the objectives of the study. Excel ensured computerized calculations 
instead of manual calculations, thereby reducing errors. These datasets were then 
exported into Stata/SE 15.1 software (Stata Corp, USA). Appropriate Stata commands 
were used to review the data for consistency and outliers. Stats SA dataset had 
categories labelled ‘unknown’ and ‘unspecified’. Such categories were coded as 
missing and accounted for in the analysis as such. 
2.3.2 NCR and Stats SA dataset 
Stats SA datasets were stratified into age group, population groups, province of usual 
residence and death year. Categories such as ‘unknown’, ‘unspecified’, which 
represents unknown age and unspecified sex respectively, were excluded from the 
cases. 
Age: 
Age was obtained as a continuous variable but was also converted to categorical. In 
the NCR data, the age of the patient at the time of diagnosis for EC was available. For 
the Stats SA data, this is the age of the patient when death secondary to EC occurred 
was provided.  
Although the actual ages were provided by both datasets, age was categorized into 5-
year interval groups in conformity with the intervals used for World Population 
Standards. The ages above 85 years were categorized as ‘85+’in the Stats SA data 
even though the world population standard extends the age group to 4 more groups 
(85-89, 90-94, 95-99, 100+). 
The age was also grouped into 2 categories namely < 50 and ≥50 years for some 
analysis. This is a categorization of women into either premenopausal (<50 years) or 
post-menopausal (≥50 years) age categories as used in other studies (Lortet-Tieulent 
et al., 2017; Olorunfemi et al., 2018). 
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Province of usual residence: 
This refers to the province and district of usual residence of the respondent. It is a 
categorical variable. 
Year of death:  
This is the year when death occurred with EC as the underlying cause. This is also 
categorical data.  
Year period of death:  
The year of death was categorized into 4-year periods viz: 1997-2001, 2002-2006, 
2007-2011, and 2012-2015. 
Population group:  
There are four racial population groups represented in the datasets viz: Black/African, 
White, Indian/Asian and Coloured. 
Anatomical site of the neoplasm:  
This is indicated by the topography codes under C54 of the ICD-10 namely: 
 C54.0 Isthmus uteri (Lower uterine segment); 
 C54.1 Endometrium; 
 C54.2 Myometrium; 
 C54.3 Fundus uteri; 
 C54.8 Overlapping lesion of corpus uteri; 
 C54.9 Corpus uteri, unspecified (Ferlay et al., 2015).  
Histological type of Corpus uteri:  
Table 2.2 shows the ICD-O-3 codes used by the NCR in grouping the datasets. The 
ICD-O-3 codes used are in line with the International Agency for Research on Cancer 





Table 2.2: Histological classification of Endometrial Cancer 
Histological type Morphology codes 
Carcinoma 8010-8574, 8576 
Sarcoma 8800-8811, 8830, 8840-8921, 8990-8991, 
9040-9044, 9120-9133, 9150, 9540-9581 
Other specified malignant 




The carcinoma histological type is further divided into Adenocarcinoma, which 
includes Mucoepidermoid and Adenosquamous carcinoma (8140-8141, 8190-8211, 
8230-8231, 8260-8263, 8310, 8380, 8382-8384, 8430, 8440-8490, 8510, 8560, 8570-
8574, 8576) and ‘other carcinomas’ comprising of ‘other specified carcinoma’ and 
‘unspecified carcinoma’ (8010-8035). This was adapted from the IARC classification 
(International Agency For Research on Cancer, 2014). 
Using the Bokhman dualistic classification, Type I EC includes ICD-0-3 morphology 
codes 8140, 8380, 8382, 8480, 8482, 8560, and 8570 (Bokhman, 1983; Felix et al., 
2010). Type II, on the other hand, includes the clear cell carcinoma and papillary 
serous carcinoma represented by morphology codes 8310, 8441 and 8460 as used 
by earlier studies (Felix et al., 2010). 
2.4 Statistical analysis 
2.4.1 Temporal Analysis of Incidence and Mortality of Endometrial Cancer 
(Objectives One and Two) 
Annual Crude Incidence and mortality rates 
The Crude Incidence Rate (CIR) of EC was determined for every year within the study 
period. CIR was calculated by dividing the yearly number of incident cases of EC by 
the mid-year population of females ≥ 15 for that year. The mid-year population was 
reported by Stats SA in the annual mid-year population estimates reports. The annual 
CIR for each population group, age group and histological type were calculated from 
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1997 to 2014. Crude Mortality Rates (CMR) was obtained by dividing the annual EC 
deaths as recorded by the Stats SA by the corresponding mid-year female population 
from 1997 to 2015. 
Age-specific incidence rates and Age-specific mortality rates for the study period were 
calculated by dividing the number of EC cases or EC deaths respectively in each age 
group category by the mid-year population for that age group. This was then multiplied 
by 100,000 to obtain the age specific mortality rate per 100, 000 women. 
Age standardised rates  
Age-Standardised Rates (ASR), which include Age-Standardised Incidence Rates 
(ASIR) and Age-Standardised Mortality Rates (ASMR), were computed by direct 
method using world standard population (Ferlay et al., 2015; Statistics South Africa, 
2015b). It was calculated by dividing the number of cases/deaths in each age group 
by the corresponding population in that age group multiplied by 100, 000 to get the 
age specific incidence/ mortality rate per 100,000 respectively. The ASIR and ASMR 
are the weighted average of the age-specific incidence and mortality rate respectively. 
The weight used was the proportion of persons in the corresponding age group of the 
world standard population (World Health Organization, 2020). The choice of standard 
population used in a study may impact on the magnitude of the standardised rates, 
thereby affecting health outcome monitoring and the subsequent health policies made 
(Robson et al., 2007). The most popularly used standard population by most studies 
in recent times (Mak et al., 2018; Olorunfemi et al., 2018) has been the 1964 Segi’s 
‘world’ standard population (Segi, Fujisaku and Kurihara, 1957). 
A more recent population structure has been proposed by the WHO (Ahmad, Boschi-
pinto and Lopez, 2001) in 2000. This ‘WHO standard population’ has a lower 
percentage of young people than the Segi’s world standard population. It has, however 
been argued by Bray et al in 2002 that the difference in absolute values of the ASRs 
still resulted in similar age adjusted relative risk (Bray et al., 2002). Segi’s world 
standard population was therefore chosen for the age standardization in this study 
because of the ease of comparison of results with those from other studies. ASRs 
using the newer WHO standard population were also calculated. The standardised 




Mortality-to-incidence ratio (MIR) was calculated for each year by dividing the ASMR 
of each year by the ASIR of that same year. Mortality-to-incidence ratio complement 
(MIR complement) was calculated using the formula (1-MIR) x 100. MIR complement 
indicates survival, the higher the MIR complement, the better the survival. 
Average Annual Percentage Change in EC 
Time trend analysis was described by plotting the CIR and CMR, ASIRs and ASMRs 
and MIR for each year within the study period, (19972014 for ASIR and 19972015 for 
ASMR) on an Excel spreadsheet. Subsequently, the trends data was imported into 
Joinpoint Desktop Software Version 4.5.0.1 (National Cancer Institute, 2017b). This 
generated the Annual Percent Change (APC) as well as Average Annual Percent 
Change (AAPC). Annual Percent Change (APC) is a way to characterize trends in 
cancer rate over time, the cancer rates are assumed to change at a constant 
percentage of the rate of the previous year. The Average Annual Percentage Change 
(AAPC), on the other hand, gives a summary measure by computing a weighted 
average of APC from a joinpoint model, over a pre-specified period. Segmental APCs 
were also reported at points of sudden change in the steepness or direction of the 
slope of the trend graph obtained. 
The methodology of the National Cancer Institute for interpreting AAPC (National 
Cancer Institute, 2018), has been slightly modified by Altekruse et al. and Mak et 
al.(Altekruse et al., 2014; Mak et al., 2018). The AAPCs were interpreted in this study 
based on the modified methodology as: Significant decrease (AAPC<0%; p<0.05); 
Non-significant decrease (AAPC<-0.5%; p>0.05); Stable (AAPC -0.5% to +0.5%; 
p>0.05); Non-significant increase (AAPC>0.5%; p>0.05); Significant increase 
(AAPC>0%; p<0.05). The modified methodology for interpreting AAPC was adapted 
in this study. 
2.4.2 Spatial distribution of Endometrial Cancer mortality 
Spatial distribution of mortality from EC among the provinces in South Africa was 
produced using ArcGIS 10.9 software (Environmental Systems Research Institute, 
Inc.). Mapping was done with the ASMR as stratified by the ‘province of usual 
residence’. The provincial ASMRs were divided into four quartiles: i) <0.5/100,000; ii) 
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0.5<1/100,000; iii) 1<1.5/ 100,000; iv) 1.52/100,000 with a key showing the colour 
representing each quartile.  
2.4.3 Predictors of Endometrial Cancer mortality among South African 
women 
Univariable and multivariable analysis of EC mortality data from Stats SA was 
conducted using Stata version 15 (Statacorp, Texas, USA) statistical Software. The 
cases were EC deaths and were coded as 1 while the control group (other female 
cancers deaths) were coded as 0. 
Univariable analysis 
Student’s t-test was conducted to compare the mean age among the EC deaths and 
death from other female cancers. Pearson’s Chi square test was utilized to compare 
the categorical variables such as age group, educational status, province of usual 
residence, marital status and smoking status between the EC group and the other 
female cancer deaths.  
Unconditional logistic regression was conducted for explanatory variables. Odds ratio 
of deaths from EC in each category of the variable were determined. 
Multi variable analysis 
Multivariable binary logistic (stepwise backward) regression was conducted using all 
the explanatory variables. The outcome was type of cancer status (EC death or other 
female cancer death). The outcome dichotomized into EC cancer status and non-EC 
female cancer death. Statistically significant levels were set at P-value < 0.05. Post 
regression diagnostics such as variance inflation factor (VIF) to check for collinearity 
were conducted. A VIF>10 suggested collinearity. Furthermore, receiver operator 
characteristic curves (ROC) of the final model were conducted. The Hosmer-
Lemeshow test was conducted to check if the data fits the model. A p-value >0.05 
showed that the data fits the model. Complete case analysis was conducted as the 




2.5 Ethical Considerations 
This study was approved by the Higher Degree Committee, Faculty of Health 
Sciences, University of Johannesburg (Appendix I). Approval was also sought and 
obtained from the Faculty of Health Sciences, Research Ethics Committee, University 
of Johannesburg with NHREC Registration number: 241112 – 035 (Appendix II). 
Access to datasets was granted by the record gate keepers of the datasets (NCR and 
Stats SA). To ensure confidentiality, the data received was anonymized. These were 
saved on an encrypted personal computer so that only the research team had access 
to them. 
2.6 Dissemination of the Research Findings 
Preliminary reports have been presented at national and international conferences. A 
full report of this study will be presented to the South African Department of Health. 
The document may serve as a guide for a more comprehensive reproductive health 
care package for women that will include EC. 
Manuscripts have been written for submission and one has subsequently been 
submitted to a peer reviewed scientific journal to add to the global knowledge about 




The study findings are presented in this chapter. The sociodemographic status of 
patients diagnosed with or who subsequently died from EC during the study period are 
described. Temporal trends in the incidence of EC by population group, histological 
type and age group as well as the trends in mortality by population group, age group 
and province are presented. The magnitude of change observed per annum was 
expressed as AAPC. Spatial maps of provincial mortality and regression models of EC 
predictors are also presented. 
3.1 Objective One: Trends in incidence of Endometrial Cancer in South 
Africa (1997 - 2014) 
3.1.1 Trends in total number of Endometrial Cancer cases by population 
group (1997 – 2014) 
The number of EC cases reported to the NCR per annum continued to rise steadily 
through the study period, with the highest number of cases recorded in 2014 in all the 
four racial population groups (See Figure 3.1 and Appendix III). There was an average 
increase of 6.1% per annum in the number of EC cases from 1997 to 2014 (AAPC: 
6.1; 95% CI: 4.6-7.5). All the population groups had an increased rate of annual EC 
cases between 5.2% and 7.0% (Coloured, [AAPC: 7.0%; 95% CI: 4.5-9.7]; Black, 
[AAPC: 6.6%; 95% CI: 4.1-9.3]; Indian/Asian, [AAPC: 6.8%; 95% CI: 5.4-8.3]; and 
White [AAPC 5.2%; 95% CI: 2.1-8.3]). All AAPC were statistically significant with P-
value: <0.001. 
 
Figure 3.1: Trends in the Cases of Endometrial Cancer by population groups in 
South Africa (1997 - 2014) 
AAPC: 6.1; P-value: <0.001
AAPC: 6.6; P-value: <0.001
AAPC: 7.0; P-value: <0.001
AAPC: 6.8; P-value: <0.001
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3.1.2 Sociodemographic and histological type distribution 
During the study period (1997 - 2014), the NCR reported 14,238 EC cases. Hence, 
the average number of EC cases per year, as reported to the NCR, was 791 cases 
per annum. More than half of the EC cases occurred among Black women (55.7%) 
while the least number of cases was among Indian/Asian women (5.7%). The mean 
age at diagnosis was 64.1±11.3 years and the age group most affected was 60-69 
(N=5, 204 [36.5%]), closely followed by the 70-79 age group (N=3,535 [24.8%]).  
Based on the dualist model used to classify the histological group into Type I and Type 
II, the majority of the EC cases were Type I (N=12,098 [85%]). Of the four major 
histological groups (Carcinoma, Sarcoma, Unspecified malignant neoplasm, other 
specified malignant neoplasm), Carcinoma was the most common group (81.5%) with 
the majority being the Adenocarcinoma variant. The sociodemographic and 
histological distribution of EC cases in South Africa is presented in Table 3.1. 
Table 3.1: Demographic and histological characteristics of EC cases (1997-2014) in 
South Africa 
Characteristics 
Endometrial Cancer cases 
N, (%) 
Total number 14,238 (100) 
Population group  
Blacks 7,932 (55.7) 
Coloureds 1,573 (11.1) 
Whites 3,405 (23.9) 
Indians/Asians 808 (5.7) 
Missing 520 (3.7) 
Age (mean ± SD) 64.1 (13.9) 
<20 23 (0.2) 
20–29 49 (0.3) 
30–39 312 (2.2) 
40–49 995 (7.0) 
50–59 2,866 (20.1) 
60–69 5,204 (36.5) 
70–79 3,535 (24.8) 
80 and above 1,021 (7.2) 
Missing 233 (1.6) 












Other specified malignant 
neoplasm 
2,038 (14.3) 
Histological subtypes  
Type I 12,098 (85.0) 
Type II 2,140 (15.0) 
Endometrial Cancer site  
Endometrium 13,275 (93.2) 
Corpus uteri 484 (3.4) 
Myometrium 358 (2.5) 
Fundus uteri 61 (0.4) 
Overlapping 53 (0.4) 
Isthmus uteri 7 (0.1) 
 
3.1.3 Trends in age specific incidence rate by population group (1997- 
2015) 
Nationally, the age group 75-79 had the highest incident cases of EC at 28.1/100,000 
women during the study period. This is closely followed by age groups 70-74, 65-69 
and 80+, which had lower age specific incidence rates of 27.9, 25.5 and 22.1 per 
100,000 women respectively. On the other hand, the early post-menopausal years, of, 
55-59 and 60-64 had lower age-specific rates of 11.8 and 19.8/100,000 women 
respectively (See Figure 3.2 and Figure 3.3).  
 
Figure 3.2: Age Specific Incidence Rate of endometrial cancer stratified by 
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Figure 3.3: Trend in Age Specific Incidence Rate of endometrial cancer stratified by 
age group categories (1997 - 2014) 
Figure 3.3 shows that women 60 years and above had relatively higher increase in the 
annual age specific incidence rates. Women within the ages of 50-59 years had slightly 
increased age specific incidence rates compared to women younger than 50 years 
who recorded no significant increase in AAPC through the 18-year period. Joinpoint 
analysis shows a statistically insignificant EC increase among age groups 15-49 and 
80+, while the other age groups (50-59, 60-69, 70-79) all had significant increases 
(Table 3.2). 
Table 3.2: Trend of Age Specific Incidence Rate in different age groups in South 
Africa (1997 – 2014) 
Age Group 15-49 50-59 60-69 70-79 80+ 
AAPC 2.8 2.5 3.0 4.6 7.5 
Confidence 
Interval 
-0.3 to 6.0 0.7 to 4.3 1.5 to 4.5 3.2 to 6.0 4.9 to 10.2 
P-value 0.1 <0.001 <0.001 <0.001 0.2 
 
3.1.4 National crude and age standardised incidence rate of endometrial 
cancer by population group 
The ASIR of EC increased from 2.5/100,000 women in 1997 and peaked in 2004 at 
4.7/100,000 women, before it slightly declined to 4.5/100,000 women in 2014 (Table 















































Table 3.3: Annual Crude and Age-Standardised Incidence and Mortality Rates of 






Cases (%) CIRb ASIRc 
Deaths 
(%) 
CMRd ASMRe MIRf 1-MIR 
1997 14284 414 (2.9) 2.9 2.50 114 (2.9) 0.8 0.70 0.28 0.72 
1998 14760 428 (3) 2.9 2.48 128 (3.2) 0.9 0.75 0.30 0.70 
1999 15237 534 (3.8) 3.5 3.09 141 (3.6) 0.9 0.79 0.26 0.74 
2000 15713 532 (3.7) 3.4 2.92 115 (2.9) 0.7 0.63 0.22 0.78 
2001 16189 728 (5.1) 4.5 3.85 163 (4.1) 1.0 0.86 0.22 0.78 
2002 16596 802 (5.6) 4.8 4.28 166 (4.2) 1.0 0.84 0.21 0.79 
2003 17002 707 (5) 4.2 3.58 170 (4.3) 1.0 0.82 0.24 0.76 
2004 15998 839 (5.9) 5.2 5.02 199 (5) 1.2 1.18 0.24 0.76 
2005 16249 799 (5.6) 4.9 4.15 163 (4.1) 1.0 0.85 0.20 0.80 
2006 16477 772 (5.4) 4.7 3.96 219 (5.5) 1.3 1.14 0.28 0.72 
2007 16703 807 (5.7) 4.8 4.00 200 (5) 1.2 0.98 0.25 0.75 
2008 17497 845 (5.9) 4.8 4.20 221 (5.6) 1.3 1.09 0.26 0.74 
2009 17751 886 (6.2) 5.0 4.26 248 (6.2) 1.4 1.21 0.28 0.72 
2010 17965 870 (6.1) 4.8 4.15 238 (6) 1.3 1.14 0.27 0.73 
2011 18229 977 (6.9) 5.4 4.46 256 (6.4) 1.4 1.17 0.26 0.74 
2012 18847 1076 (7.6) 5.7 4.64 233 (5.9) 1.2 0.99 0.22 0.78 
2013 19466 1046 (7.3) 5.4 4.29 310 (7.8) 1.6 1.28 0.30 0.70 
2014 19621 1176 (8.3) 6.0 4.54 339 (8.6) 1.7 1.32 0.29 0.71 
2015 19826 - - - 332 (8.7) 1.7 1.32 - - 
Total/ 
Overall 
324410 14238 4.4  3955 1.2  0.25  
aMid-year population of women (≥15 years) per thousand women. bCrude Incidence Rate per 100,000 women.  
cAge-standardised Incidence Rate per 100,000 women. dCrude Mortality rate per 100,000 women.  
eAge-standardised Mortality Rate per 100,000 women. fMortality Incidence Rate Ratio 
Thus, over the 18-year period (1997 - 2014), ASIR of EC was on an upward trend at 
an average rate of 3.5% per annum (AAPC: 3.5%; 95% CI: 1.7-5.4; P-value: <0.001) 
as seen in Figure 3.4 below. The CIR showed a similar pattern with values slightly 
lower in magnitude to the ASIR (Table 3.3 and Figure 3.4). 
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Figure 3.4: The trends in Age-Standardised and Crude Incidence Rates of EC in 
South Africa (1997 - 2014) 
The ASIRs obtained using the newer WHO standard population was higher than that 
obtained using Segi’s world standard population by 9% on the average while the 
increase was 12% for the ASMRs (Appendix IV). Figure 3.5 showed the pattern 
observed among the races. The Indians/Asians had the highest ASIR, followed by the 
Whites, while the Coloureds and the Blacks had the least rates during the study period.  
 
 
Figure 3.5: Annual Age-Standardised Incidence rate of Endometrial Cancer in South 
Africa stratified by population group (1997 - 2014) 
There was generally statistically significant increase in the ASIR of EC among the 
population groups except for the Whites. The AAPC in the ASIR were: Whites: 3.1% 
(95% CI: -1.0-7.3; P-value: 0.1), Blacks: 4.1% (95% CI: 2.0-6.3; P-value: <0.001), 














































AAPC: 4.1; P-value: <0.001
AAPC: 3.9; P-value: <0.001
AAPC: 3.0; P-value: <0.001
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1.6-4.4; P-value: <0.001) respectively (Figure 3.6). Table 3.4 summarizes the trend of 
the ASIR for each of the four population groups. The annual ASIR and AAPC over the 
study period (overall and by population group) are presented in Appendix V. 
 
Figure 3.6: Joinpoint regression model of AAPC of ASIR for each population group 











P-value Trend Segmental APC (%) 
Blacks 1.95 3.69 4.1 2.0 to 6.3 <0.001 
Significant 
increase 
1997 -2002 (9.09*) 
2004-2014 (0.81) 






















3.1.5 Incidence of major histological groups of EC 
The ASIR of Type I EC increased averagely by 3.1% annually (AAPC: 3.1%; 95% CI: 
1.2-5.0%; P-value: <0.001) from 2.3/100,000 to 3.8/100,000 over the study period 
while the ASIR of Type II EC increased by 8.2% on the average annually (AAPC: 8.2%; 
95% CI: 4.1-12.5%; P-value: <0.001) from 0.2 to 0.7/100,000 in the same period. (See 
Figure 3.7) 
 
Figure 3.7: Trends of the incidence of the histological type of Endometrial Cancer in 
South Africa 1997 - 2014. 
The Type I EC made up the majority of the EC cases when compared to the Type II 
EC in all the four major ethnic groups. Type I EC ranged from 81% to 93.2% in all the 
population groups, while Type II EC was between 6.8% and 19.0% (see Figure 3.8). 
 
Figure 3.8: Relative percentage of Type I and Type II EC in each population group in 
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3.2 Objective Two: Trends in Endometrial Cancer Mortality in South Africa 
(1997 - 2015) 
3.2.1 Socio-demographic characteristics of deaths from Endometrial 
Cancer 
During the study period (1997 - 2015), EC was the underlying cause of death in 3,955 
women. Table 3.5 shows the socio-demographic characteristics of patients with EC 
deaths. The average annual number of deaths was 208 per annum, increasing from 
114 deaths in 1997 to 344 deaths in 2015, nationally (as shown in Figure 3.9). 
Table 3.5: Socio-demographic characteristics of EC deaths (1997 - 2015) in South 
Africa 
Characteristics 
Endometrial Cancer deaths 
N, (%) 
Total number 3,955 (100) 
Racial population group  
Blacks 2,153 (54.4) 
Coloureds 404 (10.2) 
Whites 474 (12.0) 
Indians/Asians 128 (3.2) 
Missing 796 (20.1) 
Age (mean ± SD) 67.75 (11.91) 
<20 4 (0.1) 
20-29 10 (0.3) 
30–39 80 (2.0) 
40–49 224 (5.7) 
50–59 616 (15.6) 
60–69 1,300 (32.9) 
70–79 1,229 (31.1) 
80 and above 491 (12.4) 
Missing 1 (0.0) 
Marital status  
Never married 903 (22.8) 
Married 1,149 (29.1) 
Widowed 472 (11.9) 
Divorced 671 (17.0) 
Missing 760 (19.2) 
Smoking status  
Yes 167 (10.2) 
No 1,479 (37.4) 
Missing 2,309 (58.4) 
Highest education  
36 
No education 309 (7.8) 
Primary school 410 (10.4) 
High school 645 (16.3) 
Tertiary 88 (2.2) 
Missing 2,500 (63.3) 
Province of Usual Residence  
Eastern Cape 382 (9.7) 
Free State 300 (7.6) 
Gauteng 955 (24.1) 
KwaZulu-Natal 566 (14.3) 
Limpopo 245 (6.2) 
Mpumalanga 170 (4.3) 
Northern Cape 138 (3.5) 
North West 179 (4.5) 
Western Cape 594 (15.0) 
Unknown 426 (10.8) 
 
 
Figure 3.9: Overall number of EC deaths by population groups as reported to Stats 
SA (1997 - 2015) 
Figure 3.9 shows that the majority of the deaths occurred among the blacks while the 
least number of deaths were among the Indian/Asian.  
Less than one-tenth of the deaths occurred among women younger than 50 years 
(318/3,955 deaths, 8%), while the majority of the deaths were among women ≥50 
years (3,636/3,955 deaths, 92%). Age groups 60-69 (N=1,300/3,955, 32.9%) and 70-
79 (N=1,229/3,955 deaths, 31%) accounted for about two thirds of all deaths resulting 
from EC (Table 3.5). The mean age at death was 67.75 (±11.91) years. 
AAPC: 5.9; P-value: <0.001
AAPC: 13.2; P-value: <0.001
AAPC: 81.8; P-value: <0.001
AAPC: 84.2; P-value: <0.001
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More than 50% of the smoking status and educational attainment of the patients who 
died was not stated. However, on complete case analysis, only 10% of the women 
who died from EC were smokers while the majority (93.9%) did not have tertiary 
education. The highest number of deaths occurred at Gauteng province (N=955, 24%) 
followed by Western Cape (N=594, 15%). The least EC death occurred in Northern 
Cape Province (N=138, 3.5%). 
3.2.2 National crude and age-standardised mortality rate of endometrial 
cancer by population group in South Africa (1997 - 2015) 
The overall national ASMR increased through the study period by an average of 3.7% 
per annum (AAPC 3.7%; 95% CI: 2.7-4.7; P-value: <0.001) from 0.7 per 100,000 
women in 1997 to 1.4/100,000 women in 2015 as illustrated in Figure 3.10.  
 
Figure 3.10: Age-Standardised and Crude Mortality Rates of endometrial cancer in 
South Africa (1997 - 2015) 
A similar upward trend was observed for the Crude Mortality Rate (CMR) at the 
national level. Figure 3.11 shows the average annual increase of 4.5% (AAPC: 4.5%; 
95% CI: 3.6-5.3; P-value: <0.001) in the national ASMR over the study period. 
The ASMR of each of the population group revealed that there were marked racial 
disparities in the trends of EC mortality. This varied markedly across the years within 





























































































































Figure 3.11: Trend of the overall ASMR of endometrial cancer in South Africa (1997 - 
2015) (Joinpoint graph) 
 
Figure 3.12: ASMR of endometrial cancer stratified by population group (1997 – 
2015). 
While there was a general upward trend in the mortality of all the population groups, 
the White population group had the highest rate of rise in mortality (AAPC = 16.3%, 
95% CI: 8.4 – 24.7, P-value < 0.001) while the lowest (insignificant) increase occurred 
among the Indian/Asian (AAPC = 1.7%, 95% CI: -3.7 - 7.5, P-value = 0.5) (Table 3.6). 
 
AAPC: 11.0; P-value: <0.001
AAPC: 5.7; P-value: <0.001
AAPC: 1.7; P-value: 0.5
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Blacks 0.196 1.430 11.0 6.1 to 16.2 <0.001 
Significant 
increase 
Coloured 0.373 1.603 5.7 2.8 to 8.7 <0.001 
Significant 
increase 
White 0.044 0.725 16.3 8.4 to 24.7 <0.001 
Significant 
increase 




3.2.3 Trends in age-specific mortality rates of EC and by population 
group (1997- 2015) 
Women between the ages of 15 and 49 years had a decline in mortality rates over the 
period 1997 - 2015. However, this was not statistically significant (AAPC: -1.6%; P-
value: 0.3). Women who were 50 years and older had an increase in mortality rates 
over the period, with older women having higher mortality rates. The age group 80+ 
had an average annual increase in mortality rate of 7.5% (AAPC: 7.5%; 95% CI: 4.9-
10.2; P-value: <0.001) while age groups 50-59, 60-69, 70-79 had AAPC values of 
1.9% (95% CI: 0.4-3.4; P-value: <0.001), 4.13% (95% CI: 2.9-5.4; P-value: <0.001) 
and 4.7% (95% CI: 4.7-10.2; P-value:<0.001) respectively.  
 
Figure 3.13: Age- Specific mortality rate of Endometrial Cancer stratified by the age 
group categories (1997 – 2015) 
The mortality rate of EC among the women in the non-menopausal age group of 15-
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group of ≥50 years old, it was highest among the age group 80+ age group at 17.90/ 
100,000 women in 2013. This is shown in Figure 3.13. Also, see Appendix VI for the 
age-specific mortality rate for each of the year within the study period. 
In the cumulative age-specific mortality rate, pattern of EC over the 19-year period by 
population groups, (as depicted in Figure 3.14), indicates a gradual increase from the 
age 50 years. This became a steep rise from the age 60 years in all the population 
groups, with the White population having the least gradient. However, while the 
cumulative age-specific mortality rates of the White and Coloured population groups 
experienced steady increases throughout the age groups, the Black and Indian/Asian 
population groups peaked at the age group of 70-74 years. 
 
Figure 3.14: Cumulative Age Specific Mortality Rate of Endometrial Cancer in South 
Africa stratified by population group 
3.2.4 Trends in EC mortality in South Africa by province of usual 
residence (1997 - 2015) 
During the study period, eight out of the nine provinces showed an increase in mortality 
(Table 3.7). KwaZulu-Natal Province had the highest increase in ASMR from EC, 
increasing from 0.3 in 1997 to 1.2/100,000 women in 2015 (AAPC: 8.2%; 95% CI: 5.4-
11.1; P-value: <0.001). Only Northern Cape showed a decline in mortality with AAPC 
of -1.2%. This is however not statistically significant (P-value: = 0.5). Table 3.7 shows 
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Table 3.7: Annual Average Percent Change (AAPC) in ASMR in South African 
provinces from 1997 to 2015. 




Eastern Cape 6.1 3.6-8.7 <0.001 Significant increase 
Free State 3.1 0.3-6 <0.001 Significant increase 
Gauteng 3.3 1.5-5.2 <0.001 Significant increase 
KwaZulu-Natal 8.2 5.4-11.1 <0.001 Significant increase 
Limpopo 4.9 2.2-7.7 <0.001 Significant increase 
Mpumalanga 5.3 0.0-10.8 <0.001 Significant increase 
*Northern Cape -1.2 -4.4-2.1 0.5 Insignificant decrease 
Northwest 7.53 3.3-12.0 <0.001 Significant increase 
Western Cape 6.10 4.3-7.9 <0.001 Significant increase 
* not statistically significant.  
The provincial age-standardised mortality rates are presented in Figure 3.15 (a)-(i) 
with the Northern Cape and Western Cape recording the highest values over the study 
period. See Appendix VII for the ASMR in the provinces during each year of the study. 
Mpumalanga (0.07 per 100,000 women) had the lowest ASMR at the commencement 
of the study, while Limpopo (0.6 per 100, 000 women) had the lowest at the end of the 
study. The mean age at death from EC in the provinces ranged from 65.42 ± 12.84 
years in Mpumalanga to 67.89 ± 11.51 years in the Western Cape. However, the slight 
difference in provincial mean age was not statistically significant (χ2: 32.84; P-value: 
0.28). Well over 80% of EC deaths occurred in the postmenopausal age (≥50 years) 
in all nine provinces. Mpumalanga had the highest percentage of death (12.35%) for 
the <50 years age category and these differences were significant (χ2: 18.1; P-value: 







Figure 3.15: Age standardised mortality rate (per 100,000) of EC by province of usual residence for (a) Northern Cape, (b) Western 
Cape, (c) North West, (d) Mpumalanga, (e) Free State, (f) Gauteng, (g) Kwazulu-Natal, (h) Eastern Cape and (i) Limpopo 
 












 (g) (h) (i) 
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3.3 Objective Three: Spatial representation of the Mortality of Endometrial 
Cancer in South Africa by Province 
Figure 3.16 shows the geographical distribution of the ASMR among the provinces. 
The figure displays five maps showing the geographical distribution of the ASMR of 
EC at 5-year intervals from the commencement of the study (1997) to the last year 
(2015) of the study.  
In 1997, six of the nine provinces (Eastern Cape, KwaZulu-Natal, Northern Cape, 
Western Cape, Limpopo, Mpumalanga) had ASMRs less than 0.5/100,000 women 
which was in the first quartile (<0.5/100,000 women) of mortality. Three other 
provinces (Northern Cape, Free State and Gauteng) were in the third quartile (1-
1.49/100,000 women) of mortality in the same year (Figure 3.16A). 
By 2002, only two provinces (Limpopo, Eastern Cape) were in the first quartile (Figure 
3.16B), four were in the second quartile (0.5-0.99) while the remaining three provinces 
(Northern Cape, Free state, Western Cape) were in the third quartile. In 2012, no 
province had mortality in the first quartile again, with the majority of the provinces (5) 
having mortality rates in the second quartile (Figure 3.16D). Furthermore, by the year 
2015 (Figure 3.16E), only two provinces (Limpopo, Mpumalanga) had mortality rates 
within the second quartile as 7 of the nine provinces had mortality rates in the third (1-
<1.5/100,000 women) and fourth (1.5-2/100,000 women) quartiles.  
3.3.1 Mortality to Incidence Ratio as an indicator of survival 
The mortality-to-incidence ratio (MIR) of EC in South Africa between 1997 and 2014 
showed a minimal and insignificant increase from 0.28 in 1997 to 0.29 in 2014, but the 
overall AAPC over the 19 year period showed a non-significant decline in MIR with an 
AAPC of -0.3% (95% CI: -2.6-2.2; P-value: 0.8). However, since 2001, there has been 
a significant increase in the trend of MIR in South Africa with a segmented APC of 
2.0% (95% CI: 0.4-3.7; P-value: <0.001) between 2001 and 2014. This is as shown in 
Figure 3.17. The MIR complement, indicating survival, reduced from 78% to 71% 
between 2001 and 2014. The MIR and MIR complement for each year of the study 




Figure 3.16: Spatial age-standardised mortality rates (ASMR) of Endometrial Cancer 







Figure 3.17: Joinpoint regression analysis of MIR in EC deaths in South Africa (1997 
– 2014) 
MIR in each of the four population groups showed that the greatest rate of change was 
among the Black population at AAPC of 5.9% (95% CI: 0.8-11.1; P-value: <0.001). 
This was closely followed by the Coloureds who had a 4.2% rise in MIR. The rise in 
MIR shows a worsening in survival among these population groups. The Whites and 
Indians/Asians had an insignificant increase and decrease respectively. The trend in 
MIR by population group is summarized in Table 3.8. The MIR in each of the 
population group for the study period can be found in Appendix IX. 











All 0.3 -1.3 to 1.8 0.7 Insignificant increase 
Blacks 5.9 0.8 to 11.1 0.001 Significant increase 
Coloured 4.2 0.3 to 8.3 0.001 Significant Increase 
White 2.5 -0.7 to 5.8 0.1 Insignificant increase 




3.4 Objective Four: Factors Associated with EC mortality in South Africa 
(1997 - 2015) 
The Stats SA mortality data was used for the case control arm of the study. There 
were 322,979 cancers that resulted in death among South African women during the 
study period. A total of 70,157 female cancer deaths were selected into the case 
control study. The cases were the 3,955 EC deaths (5.3%) while the appropriate 
controls were 66,202 other female cancers, having excluded all the cancers 
associated with EC (Table 2.1). 
3.4.1 Sociodemographic differences between EC cases and other non-
related female cancers in South Africa 1997 - 2015 
The study showed that deaths from EC occurred at a more advanced age (mean age: 
66.75±11.91 years) compared to other female cancers (mean age: 59.65±18.71 
years). Likewise, a higher percentage (92%) of women who died of EC were in the 
post-menopausal age group (>50 years) compared to the control group (74%). The 
sociodemographic differences between the two groups is statistically significant with 
P-value <0.001. The sociodemographic characteristics of each group is shown in 
Table 3.9. 
Table 3.9: Sociodemographic differences of Endometrial Cancer deaths and other 












Total number 3,955 (100) 66,202 (100) 70,157 (100)  
Age (mean ± SD) (67.75 ± 11.91) (59.65 ± 18.71) (60.05 ± 18.47) <0.001 
< 50 318 (8.1) 17,345 (26.2) 17,663 (25.2) <0.001 
≥ 50 3,633 (91.9) 48,760 (73.8) 52,393 (74.8)  
Marital status 
Never married 903 (28.25) 18,720 (33.87) 19,622 (33.56) <0.001 
Married 1,149 (35.95) 18,463 (33.41) 19,611 (33.54)  
Widowed 472 (14.78) 5,922 (10.71) 6,394 (10.94)  
Divorced 671 (21.01) 12,164 (22.01) 12,835 (21.95)  
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Smoking status 
Smoker 167 (10.15) 4,271 (16.66) 4,438 (16.27) <0.001 
Non-smoker 1,479 (89.85) 21,359 (83.34) 22,837 (83.73)  
Highest education 
No education 309 (21.28) 4,321 (18.3) 4,630 (18.47) <0.001 
Primary school 410 (28.24) 4,753 (20.13) 5,163 (20.6)  
High school 645 (44.42) 12,911 (54.69) 13,556 (54.09)  
Tertiary 88 (6.06) 1,624 (6.88) 1,712 (6.83)  
Province of Usual Residence 
Western Cape 594 (16.84) 10,275 (17.89) 10,869 (17.83) <0.001 
Eastern Cape 382 (10.8) 7,307 (12.72) 7,688 (12.61)  
Northern Cape 138 (3.91) 1,931 (3.36) 2,069 (3.39)  
Free State 300 (8.5) 3,848 (6.7) 4,148 (6.8)  
KwaZulu-Natal 566 (16.04) 9,653 (16.81) 10,219 (16.76)  
North West 179 (5.07) 3,180 (5.54) 3,359 (5.51)  
Gauteng 955 (27.07) 14,671 (25.55) 15,626 (25.63)  
Mpumalanga 170 (4.82) 3,077 (5.36) 3,247 (5.33)  
Limpopo 245 (6.94) 3,488 (6.07) 3,733 (6.12)  
Period of Diagnosis 
1997-2001 658 (16.65) 14,963 (22.6) 15,621 (22.27) <0.001 
2002-2006 917 (23.2) 16,910 (25.54) 17,827 (25.41)  
2007-2011 1,163 (29.43) 17,794 (26.88) 18,957 (27.02)  
2012-2015 1,214 (30.72) 16,535 (24.98) 17,749 (25.30)  
 
3.4.2 Logistic regression analysis model of the association between 
endometrial cancer deaths and sociodemographic factors 
A logistic regression model of EC deaths in South Africa was designed based on the 
available variables (age, marital status, educational status, smoking status, province 
of usual residence, and year of death). 
Univariable analysis 
Univariable analysis of EC versus other female cancers was evaluated using the 
variables: age≥50, marital status, educational status, smoking status, Province of 
usual residence as well as ‘year period of death’. All the variables were individually 
associated with EC deaths except for category of patients whose province of usual 
residence were Free State, Gauteng and Limpopo (P-values of 0.41, 0.32 and 0.88 
respectively). The reference group for each of the predictor variables is indicated in 
Table 3.10. 
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Furthermore, the univariable analyses showed that women in the postmenopausal 
age-group (≥50 years) had 4 times the odds of death from EC as compared to women 
younger than 50 years (UOR: 4.06; 95% CI: 3.62-4.56; P-value: <0.001). Divorcees 
had about 14% higher odds of EC deaths as compared to the never married women 
(UOR: 1.14; 95% CI: 1.03-1.27; P-value: 0.01). Lower educational status such as 
primary school level also had raised odds of EC deaths by 21%. On the other hand, 
smokers had 47% reduced odds of EC deaths. 
Table 3.10: Unadjusted and adjusted odd ratios of the risk of EC death 
 Univariable Analysis Multivariable Analysis 
Factor UOR 95% CI P-value Adj OR 95% CI P-value 
Age       
< 50 Ref Ref Ref Ref Ref Ref 
≥ 50 4.06 3.62-4.56 < 0.001 3.98 3.14-5.03 < 0.001 
Marital status       
Never married Ref Ref Ref Ref Ref Ref 
Married 1.29 1.18-1.41 < 0.001 0.85 0.72-1.00 0.049 
Widowed 1.65 1.47-1.86 < 0.001 0.89 0.72-1.08 0.233 
Divorced 1.14 1.03-1.27 0.010 0.73 0.59-0.89 0.002 
Smoking status       
Non-Smoker Ref Ref Ref Ref Ref Ref 
Smoker 0.53 0.48-0.67 < 0.001 0.53 0.43-0.65 < 0.001 
Highest education       
No education Ref Ref Ref Ref Ref Ref 
Primary school 1.21 1.03-1.41 0.016 1.18 0.98-1.43 0.077 
High school 0.70 0.61-0.80 < 0.001 0.79 0.66-0.94 0.009 
Tertiary 0.76 0.59-0.97 0.026 0.82 0.61-1.11 0.197 
Province of Usual 
Residence 
      
Northern Cape Ref Ref Ref Ref Ref Ref 
Eastern Cape 0.73 0.60-0.89 0.002 0.99 0.69-1.41 0.951 
Free State 1.09 0.89-1.34 0.414 1.32 0.91-1.91 0.142 
Gauteng 0.91 0.76-1.10 0.322 1.05 0.74-1.47 0.797 
KwaZulu-Natal 0.82 0.68-0.99 0.044 1.06 0.76-1.48 0.740 
Limpopo 0.98 0.79-1.22 0.875 1.12 0.77-1.62 0.560 
Mpumalanga 0.77 0.61-0.97 0.029 0.97 0.66-1.43 0.884 
North West 0.79 0.63-0.99 0.041 1.01 0.66-1.54 0.968 
Western Cape 0.81 0.67-0.98 0.030 1.00 0.69-1.46 0.980 
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Period of Diagnosis       
1997-2001 Ref Ref Ref Ref Ref Ref 
2002-2006 1.23 1.11-1.37 < 0.001 1.22 0.97-1.54 0.091 
2007-2011 1.49 1.35-1.64 < 0.001 1.26 1.00-1.58 0.046 
2012-2015 1.67 1.51-1.84 < 0.001 1.46 1.17-1.83 0.001 
 
Multivariable analysis 
After adjusting for confounders, the odds of EC death increased almost four-fold 
among women who were ≥50 years in age (AOR: 3.98; 95% CI: 3.14-5.03; P-value: 
<0.001) as compared to women who were< 50 years. While the odds of EC deaths 
decreased among divorced women (AOR: 0.73; 95% CI: 0.59-0.89; P-value: 0.002) 
by 27% compared to never married women. Additionally, smoking conferred some 
protection by reducing the odds of EC deaths by 47% (AOR: 0.53; 95% CI: 0.43-0.65; 
P-value: <0.001). Women who had high school education as their highest educational 
status had decreased odds of EC deaths (21% decrease) compared to those with no 
education (AOR: 0.79; 95% CI: 0.66-0.94; P-value: 0.009). 
The odds of EC deaths increased as the year-periods increased (Table 3.10). For 
instance, the odds of dying from EC was 1.46 times higher in the 2012-2015 period in 
contrast to the 1997-2001 period (AOR: 1.46; 95% CI: 1.17-1.83; P-value: 0.001). 
The VIF was 1.03 which showed that there was no collinearity. However, the P value 
of Hosmer -Lemeshow test was <0.001 which showed that the data does not fit the 
model. The area under the receiver operator characteristics curve was 0.66 which 




4.1 Chapter Overview 
The key findings of the research are presented in this chapter. These are also 
compared with results from previous related national and international studies. The 
implications of our findings within the context of South Africa are also discussed. The 
chapter concludes with the strengths and limitations of the study.  
4.2 Summary of Study Findings 
The study showed an overall upward trend in the ASIR and ASMR of EC in South 
Africa from 1997 - 2015. There were approximately, 791 cases of EC annually and 
208 deaths from EC per annum during the study period. The rate of increase in both 
ASIR and ASMR were similar, with AAPC of 3.5% and 3.7% respectively. All 
population groups had an annual increase in ASIR between 3.0% and 4.1% per 
annum. The Blacks had the highest rate of increase of 4.1%. Post-menopausal 
women, divorcees (in relation to the married and widowed), non-smokers and women 
with no education had higher odds of EC deaths. 
Mortality to incidence ratio was stable during the study period. However, from 2001, 
survival rates worsened from 78% to 71%, with a segmental APC in MIR of 2% 
between 2001 and 2014. 
4.3 Trends of Endometrial Cancer in South Africa 
4.3.1 Incidence rates and trends 
The number of new cases of EC in the Southern African region has been described 
as the highest in Africa with South Africa being a major contributor to the new cases 
(Ferlay and Rous, 2017). Cancer Incidence in Five Continents (CI5) published ASIR 
of 2.0/100,000 women in 2012 (International Agency For Research on Cancer, 2014). 
This ASIR is lower than the ASIR of 4.6/100, 000 women that we found in our study 
for the year 2012. (Appendix IV)   
The South African incidence data that was utilized by the International Agency for 
Research on Cancer (publisher of CI5 XI) was a population-based cancer registry 
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located in the Eastern Cape province of South Africa (Bray et al., 2018) known as   
PROMEC (‘Programme on Mycotoxins and Experimental Carcinogenesis’). While the 
NCR, a pathology-based cancer registry which receives information on histologically 
diagnosed cancers from all over the country, was the source of incidence data for this 
present study.  
Although PROMEC is a population-based registry that met the criteria for inclusion in 
the CI5 global cancer registry, the data from this registry may not be representative of 
the entire South African population as it primarily serves the Eastern Cape Province. 
However, this study showed that more cases of EC were reported to NCR. This is 
possibly because the catchment area of the NCR is now the whole country.  
The NCR is a passive registry of all pathologically confirmed cancer cases and may 
also miss some cancer cases either because of under-reporting by laboratories or non-
diagnosis of cases. To obviate the perceived deficiencies of data from both PROMEC 
and NCR, four population-based cancer registries were proposed to be established in 
the country (Singh, Ruff, et al., 2016). In this regard, the Ekurhuleni Population based 
cancer registry has commenced activities in January 2017.  
The South African EC ASIR of 4/100,000 women is lower than the rates observed in 
high income countries in Europe and North America (ASIR of 19/100,000 in Slovakia, 
ASIR of 16/100,000 in Canada, ASIR of 18/100,000 in USA) in 2007 (Weiderpass et 
al., 2014; Lortet-Tieulent et al., 2017). Nevertheless, the upward trend in the major EC 
indicators (ASIR and MIR of  EC) in South Africa may be a reflection of worsening 
indices of the Non Communicable Diseases (NCD), particularly in African countries 
with rapid socioeconomic transition (Jemal et al., 2010; McCormack and Boffetta, 
2011; Ferlay et al., 2015; Bray et al., 2018). The increasing trends in EC rates among 
South African women may be partly related to the increasing prevalence of obesity in 
the country after the commencement of multi-racial democracy in 1994 that led to 
improved socio-economic status of majority of the citizens of the country (World Health 
Organisation, 2015; Sartorius et al., 2015; Cois and Day, 2015). Thus, South African 





4.3.2 Mortality rates and trends of Endometrial cancer 
Although we found that the overall ASMR in South Africa in 2012 was about 1.0/ 
100,000 women, Ferlay et al for 2012 estimated 1.3 and 1.8/100,000 deaths for Africa 
and Southern Africa respectively. This shows a close range to the estimate for the 
Southern African region. Our study showed that EC mortality rates in South Africa 
increased during the 19-year study period by 3.5% per annum. In contrast, estimates 
from Global Cancer Incidence, Mortality and Prevalence (GLOBOCAN) studies 
suggest that the trend in global ASMR of EC is stable at 1.8/100,000 women between 
2012 and 2018 (Ferlay et al., 2015; Bray et al., 2018). 
The regional variation in ASMR – estimates of: 1.3 (Africa), 1.8 (Southern Africa), 1.3 
(Eastern Africa), 1.4 (Western Africa) and 0.9 (Northern Africa) /100,000 EC deaths 
as well as 2.0 (Americas), 1.5 (Asia), 2.2 (North America), 2.6 (Europe), 3.8 
(Melanesia) /100,00 women deaths – and survival pattern may account for the overall 
stability in the global estimates. Despite the high ASIR in HICs, the ASMRs are 
relatively low. This may be due to early EC stage at presentation in the hospital and 
availability of better means of EC treatment or management in the HICs. 
Since EC is potentially curable if detected early, the mortality rate may not necessarily 
increase with increasing incidence in countries with good surveillance and treatment 
modalities (Torre et al., 2017). However, countries with poor awareness of EC among 
their womenfolk may lead to late EC stage of presentation. Also, inadequate diagnostic 
and treatment facilities may have increased EC mortality trends with increasing 
incidence. Thus, the increasing mortality trends that mirror the incidence trends in 
South Africa may suggest that the health system is not responding adequately to the 
increasing incidence rates of EC in the country.  
This pattern may also suggest that the EC patients were presenting late to the hospital 
with attendant increased mortality. Typically, EC has good prognosis with up to 80% 
five-year survival rate (National Cancer Institute, 2017a). Our study also suggests that 
the five-year survival rate of EC in South Africa was as high as 70%. However, our 
study showed that the MIR from 2001 to 2014 suggests a decline in five-year survival 
rate of EC from 78% to 71%, which calls for concerted efforts aimed at providing 
adequate therapeutic, curative and palliative EC care in South Africa. 
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Considering the year-periods, the mortality rates over 4-year periods (1997-2001, 
2002-2006, 2007-2011, 2012-2015) showed higher odds of EC death with ‘later year 
periods’ of the study. The odds of having EC death increased by 46% in 2012-2015 
when compared to the year period ‘1997-2001’. The result of this analysis further 
showed an upward trend of the burden of EC with increasing years.  
This study also found that there was increased incidence of the two broad histological 
types (Type I and II) of EC during the study period. However, the more aggressive 
histological group of EC, (Type II), had higher rate of increase (AAPC: 8%) than the 
less aggressive EC type (Type I, AAPC:3%). Such histological trends may have 
increased the EC cases with higher fatality, thereby leading to a higher ASMR, MIR 
and reduced five-year survival rate.  
4.3.3 Racial Disparity in Endometrial cancer 
Our study showed that there was racial disparity in the incidence and mortality of EC 
in South Africa. While the White and the Indian/Asian population groups had the 
highest incidence rates of EC, the Black and Indian/Asian population group had the 
highest mortality rates during the study period. This pattern was also reported in the 
United States of America (USA) where the incidence of EC was higher among whites 
as compared to the  black population (Lortet-Tieulent et al., 2017).  
Other studies in the USA have also shown that blacks have a lower incidence but 
higher mortality of EC than whites (Cote et al., 2015; Baskovic et al., 2018). The 
reasons for this pattern may be related to histological and social differences among 
the races. However, emerging evidence suggest racial molecular differences as a 
causal pathway for the observed racial disparity in EC incidence and mortality (Long, 
Liu and Bristow, 2014). 
The Black population group in South Africa recorded the greatest rate of increase in 
the incidence rate over the study period while the whites had an insignificant increase 
in AAPC of ASIR (AAPC-3.1%, P value-0.1). Similar trends were reported by Lortet-
Tieulent et al. in the USA. The incidence rate among blacks increased since the 1990s, 
while the rate of increase among Whites had relatively slowed down. (Lortet-Tieulent 
et al., 2017).  
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The South African EC racial pattern may be related to the rapid epidemiological 
transition in South Africa since the commencement of multi-racial democracy in the 
country in 1994. The increased prosperity was more pronounced among the black 
population (Mariotti and Fourie, 2014) and thus may portend the increasing risk factors 
for EC in the Blacks. 
4.3.4 Provincial trends and spatial distribution of mortality from 
Endometrial Cancer 
All the nine South African provinces had an increased EC mortality rate from our study, 
(though to varying degrees). Northern Cape and Western Cape provinces had the 
highest provincial EC mortality rates during the study period, while Limpopo and 
Mpumalanga had the lowest rates. This pattern is similar to the report on the 
distribution of all cancers in South Africa provinces (Made et al., 2017). It is noteworthy, 
that the majority of people living in the Western Cape Province have higher socio-
economic status that can predispose them to obesity and to EC compared to some 
other provinces (Made et al., 2017). The ‘province of usual residence’ was utilized 
instead of the ‘province of diagnosis’ in order to prevent skewing the results towards 
more developed provinces with oncology centres, such as the Gauteng Province.  
4.3.5 Histological trends 
Similar to findings from other studies, majority of EC cases in South Africa were of the 
adenocarcinoma variant.  (Lortet-Tieulent et al., 2017; Muhammad et al., 2017; 
Alshahrani et al., 2018). Also, the global ratio of Type I to Type II EC is approximately 
8-9:2-1 (Scully, 2003; Ali, 2014; Weiderpass et al., 2014). The ratio observed 
nationally for South Africa in this study was 5.7:1. This indicates a higher Type II 
disease occurrence relative to the Type I in South Africa as compared to the global 
pattern. This may be because the black population have a higher tendency to develop 
Type II EC disease unlike other races (Guttery et al., 2018).  
Type II EC has a higher fatality rate than Type I (Malik et al., 2016). Thus, the increased 
incidence of Type II EC at an average of 8% per annum (AAPC: 8%) in South Africa, 
may increase the mortality rate of EC as compared to other countries.  
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4.3.6 Predictors of Endometrial Cancer 
Age and Endometrial Cancer  
In this study, the mean age of incidence was 64 years. This is similar to the peak age  
of incidence of EC (60-69 years) in Egypt (Alshahrani et al., 2018), and USA (61 
years), which are middle and high income countries respectively. However, a lower 
mean age of EC incidence of 54 years was reported from Nigeria, a middle-income 
country (Muhammad et al., 2017).Our study confirmed that EC is a cancer of post-
menopausal women since more than 90% of the cases and mortality occurred in 
women older than 50 years. Furthermore, the regression model showed that women 
above 50 years, (usually postmenopausal), had strong association (odds ratio of about 
4) with EC death when compared to women <50 years. Nonetheless, surveillance 
among younger women is still necessary as some women younger than 50 years were 
reported in both the incidence and mortality data in the study.  
The mean age of EC incidence (64 years) lags the mean age at EC death (66.7years) 
by barely three years. This may suggest at the population level that the survival from 
diagnosis to death is poor at about 3 years. A late diagnosis of EC cases may also be 
a reason for the late age of diagnosis of EC in this study population. This result 
requires further confirmation with hospital based longitudinal/cohort studies. Post-
menopausal women should be counselled and appropriate information about EC risks 
should be provided in the community to increase early diagnosis and treatment (Ferlay 
et al., 2015). 
Smoking and Endometrial Cancer 
Our study revealed that tobacco smoking is a protective factor, reducing the odds of 
dying from EC by 47%. Previous researchers also found similar result. (Loerbroks et 
al., 2007; Zhou et al., 2008; Plagens-Rotman, Żak and Piȩta, 2016). It is worth noting 
that previous works had studied the relationship between smoking and the evolution 
of EC. However, we evaluated the relationship between smoking and EC mortality and 
still found a similar protective pattern. Thus, the current aggressive smoking control 
programme in South Africa (Wisdom et al., 2018) may have an unintended risk of 
increasing the EC rates and mortality among South African women. Nevertheless, 
tobacco smoking is a major cause of premature mortality globally and hence should 
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not be promoted based on its impact on EC. Also, women who are involved in smoking 
cessation programmes should be followed-up for the risk of EC, especially if other risk 
factors are present.  
Marital status and EC 
Our study showed that women who were married or previously married (divorced, 
widowed, or separated) had lesser odds of mortality from EC as compared to women 
who had never been married. Studies have shown that lower parity, especially 
nulliparity, is associated with increasing risk of EC (Gleicher, 2013). However, 
marriage could be more easily associated with parous experiences and the marital 
status of EC deceased may largely be extrapolated as a surrogate for parity. The 
majority of married or previously married women were likely to be parous as compared 
to women who were not married. The apparent protective effect of marriage on EC 
mortality among our study population may be in line with studies that showed that 
lower parity increases the risk of EC. Similarly, family support and other psychosocial 
impacts of a family life may partly explain the reduced EC mortality among the women 
who had ever married. Our findings may be in line with the postulation that the reported 
decline in total fertility rate across South Africa (Statistics South Africa, 2015a) may be 
fuelling the increasing trends in EC rates in the country.  
Educational attainment:  
Women with higher educational attainments are likely to be economically empowered 
to pay for cancer screening and healthcare, hence having a better health-seeking 
behaviour (Abaerei, Ncayiyana and Levin, 2017).Thus, in line with the usual 
association between educational attainment and cancer, lesser likelihood of EC 
deaths should occur with increasing educational attainment (Plagens-Rotman, Żak 
and Piȩta, 2016). In agreement with this, our study revealed that women with high 
school educational attainment had a 21% reduced odds of mortality due to EC 
compared to that of women with no education. 
4.4 Strengths of the study 
Our study, for the first time, describes the trend of a hitherto neglected cancer that has 
begun to subtly rise over the last two decades globally, especially in regions with 
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historically low incidence rate. This study therefore helps to heighten interest in EC 
incidence and mortality to guide preventive initiatives. The study period was for almost 
two decades hence we were able to describe an established pattern in trends of this 
type of cancer. 
The datasets that were utilized in this study were nationally representative of South 
African women at the time of the study. This allowed for a large sample size and the 
point estimates of our parameters had narrow confidence intervals.  
The study involved evaluation of both the incidence and mortality data of EC. This 
provides more data triangulation and information on the burden of the disease than 
utilizing only incidence data. 
4.5 Limitations of the study 
Limitations of the study include: 
1. The datasets, being a pair of secondary data, had the problems of routinely 
collected secondary data such as missing variables, missing observations and 
misclassification. There may be bias due to the missing values on some variables 
such as smoking status. Multiple imputations are a possible method of handling 
missing data. However complete case analysis was done instead of multiple 
imputations. This is because multiple imputations may not be efficient since we 
were not sure if the missing data was random or not (Héraud-Bousquet et al., 
2012). However, hot-deck multiple imputation was done for the NCR data  
2. Also, some late entries of EC cases may occur as some hospitals and 
laboratories may not report cases on time. The data available in NCR at the data 
set request was updated until 2014, to accommodate late entries. 
3. The unavailability of some variables in the datasets was also a limitation of the 
study. This may account for the poor fit of the regression model as assessed by 
the Hosmer-Lemeshow test. For instance, body mass index (BMI) as an index of 
obesity, was not available for analysis. Similarly, the HIV status of the participants 
may be useful since South Africa has a high proportion of people living with HIV.  
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CHAPTER FIVE 
5 CONCLUSION AND RECOMMENDATION 
Conclusions based on findings of the study and recommendations are presented in 
this chapter. 
5.1 Conclusions 
This study has reported the trends in the incidence and mortality rates of EC by, 
province, histological type and population and age groups in South Africa from 1997 
to 2014 based on data from the NC Rand Stats SA. Sociodemographic predictors were 
also evaluated. The study concluded that: 
i) The burden of EC is higher among women older than 50 years and could be 
described as largely a post-menopausal disease.  
ii) Both the ASIR and ASMR remain low (<5/100,000 women) as expected for 
LMIC. However, the national incidence and mortality rates of EC in South Africa 
increased considerably during the study period (1997 – 2015). The incidence 
rates of EC in South Africa increased for all the ethnic groups with the Black 
population group experiencing the highest increase. 
iii) The incidence of the globally less common histological Type II EC is on the 
increase in South Africa. 
iv) Mortality due to EC is also on the upward trend, with the White population group 
having the highest increase.  
v) Despite a good survival rate of EC globally, there was a decline in the five-year 
survival rate of EC in South Africa since 2001.  
vi) The map of the spatial distribution of EC deaths in the country shows the 
definite upward trend of EC in most province.  
vii) Marital status, age, educational attainment and smoking status were associated 
with EC mortality in South Africa. Among all these factors considered, smoking 
and secondary school level of education showed some protective effects 
against the occurrence of EC.  
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5.2 Recommendations 
The following recommendations are made based on the findings of this study, with a 
view to encouraging policy formulation that will aid improving surveillance, reduce EC 
rates and foster future research. 
i. Public health surveillance and preventive interventions on endometrial cancer 
should be instituted in South Africa due to the increasing EC rates. 
 Hence, public enlightenment campaign, and training of physicians about early 
diagnosis and treatment can assist to improve the prognosis and survival. The 
postmenopausal years are an important target group for these interventions. 
Medical practitioners as well as the populace especially the decade before post-
menopausal years begin (39-49), should be informed about the risk factors of 
EC such as obesity.  
ii. Women who have stopped tobacco smoking should be encouraged to check 
for sign and symptoms of EC. 
iii. Up-to-date data at the cancer registry should be encouraged through active 
reporting. A more accurate and current picture of the cancer trends will then be 
available that can be used for monitoring and evaluation. 
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Number of Endometrial Cancer cases reported to the NCR in South Africa (1997 – 2014) 
Year of 
Diagnosis 
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
All 402 415 525 515 702 798 699 824 787 762 800 838 879 860 969 1062 1027 1141 
Black 216 212 313 280 364 401 352 433 456 407 442 488 555 502 547 596 544 649 
Coloured 30 46 49 61 83 105 76 117 81 98 97 102 94 90 114 106 103 109 
Indian/Asian 26 24 20 29 42 36 36 33 39 45 50 43 46 59 52 65 67 83 





Age Standardised Rates (Segi vs WHO) 
 ASIR ASMR 
Year Segi WHO Segi WHO 
1997 2.507 2.732 0.700 0.779 
1998 2.493 2.730 0.750 0.840 
1999 3.094 3.325 0.791 0.888 
2000 2.917 3.162 0.626 0.703 
2001 3.850 4.165 0.859 0.958 
2002 4.278 4.651 0.843 0.944 
2003 3.579 3.915 0.822 0.934 
2004 5.023 5.521 1.183 1.388 
2005 4.164 4.624 0.859 0.962 
2006 3.963 4.383 1.141 1.282 
2007 4.002 4.470 0.978 1.151 
2008 4.202 4.640 1.093 1.239 
2009 4.265 4.757 1.206 1.384 
2010 4.152 4.583 1.140 1.297 
2011 4.460 4.940 1.171 1.323 
2012 4.642 5.136 0.991 1.147 
2013 4.289 4.717 1.283 1.476 





Age Standardised Incidence and Mortality Rates (with AAPC) by population group 
(a): ASIR (per 100,000 women) and AAPC of Endometrial Cancer by population group in South Africa (1997 – 2014) 
Year of 
Diagnosis 
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 AAPC 
All 2.507 2.493 3.094 2.917 3.850 4.278 3.579 5.023 4.164 3.963 4.002 4.202 4.265 4.152 4.460 4.642 4.289 4.544 3.5% 
Black 1.954 1.836 2.592 2.250 2.817 3.059 2.520 4.037 3.603 3.157 3.299 3.695 4.089 3.705 3.794 3.892 3.351 3.691 4.1% 
Coloured 2.309 3.552 3.715 4.247 5.542 6.675 4.736 8.408 4.962 5.928 5.406 5.907 5.087 4.731 5.915 5.163 4.838 5.350 3.9% 
Indian/Asian 6.195 5.476 4.174 5.714 7.528 6.983 6.355 6.210 6.309 7.104 7.704 6.363 6.331 7.779 6.862 8.813 8.579 10.807 3.0% 
White 4.135 3.818 3.769 3.789 5.736 6.490 6.425 5.624 4.817 4.717 4.404 4.169 3.920 4.416 5.683 6.007 6.250 6.708 3.1% 
 
(b): ASMR (per 100,000 women) and AAPC of Endometrial Cancer by population group in South Africa (1997 – 2014) 
Year of 
Death 
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 AAPC 
All 0.700 0.750 0.791 0.626 0.859 0.843 0.822 1.183 0.859 1.141 0.978 1.093 1.206 1.140 1.171 0.987 1.280 1.324 1.323 3.7% 
Black 0.196 0.310 0.516 0.529 0.676 0.637 0.609 0.928 0.720 0.884 0.602 0.890 0.983 0.864 1.027 0.914 1.139 1.279 1.426 11% 
Coloured 0 0.373 1.458 0.710 0.961 1.014 1.028 1.004 0.916 1.380 1.258 1.089 1.780 1.195 1.677 1.412 2.424 1.435 1.603 5.7% 
Indian/Asian 0 0 1.806 0.416 0.674 1.766 0.517 1.720 0.975 1.733 1.508 0.443 1.088 0.773 1.032 0.680 1.356 1.533 1.643 1.7% 





Age Specific EC Incidence and Mortality Rates 
 (a): Age Specific EC Incidence Rate per 100,000 women in South Africa (1997-2014) 
Year of 
Diagnosis 
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
15-49 0.38 0.37 0.52 0.56 0.67 0.66 0.66 0.53 0.69 0.48 0.73 0.48 0.58 0.59 0.58 0.67 0.62 0.60 
50-59 6.38 6.12 6.95 7.43 10.25 11.78 8.89 10.12 9.78 8.45 8.45 9.22 9.26 9.46 8.29 9.89 9.21 9.81 
60-69 15.45 14.91 19.68 16.94 23.64 27.01 20.35 31.69 23.65 23.92 21.72 27.02 24.56 24.11 27.28 27.40 26.22 28.52 
70-79 17.01 18.29 21.35 20.40 23.65 25.48 24.07 41.88 31.35 34.57 34.17 30.72 36.47 32.33 37.81 36.28 31.89 34.99 
80+ 11.53 11.99 11.61 10.91 17.49 18.42 22.27 31.75 28.86 22.33 28.21 29.06 29.21 28.42 32.91 35.56 32.06 30.07 
 
 (b): Age Specific EC Mortality Rate per 100,000 women in South Africa (1997-2015) 
Year of 
Death 
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
15-49 0.12 0.16 0.19 0.08 0.12 0.14 0.16 0.14 0.11 0.15 0.11 0.16 0.13 0.08 0.08 0.08 0.13 0.12 0.14 
50-59 1.46 2.07 1.63 1.43 1.45 1.27 1.42 1.63 1.52 2.46 1.50 1.85 1.81 2.24 2.04 2.04 2.36 1.64 2.00 
60-69 3.57 3.68 4.07 3.33 5.25 4.99 3.95 5.53 4.76 6.39 5.01 5.99 6.55 6.17 6.88 5.10 6.52 7.48 8.32 
70-79 7.21 5.51 6.66 5.10 7.46 7.43 7.53 13.50 8.29 8.40 10.56 10.97 10.94 11.42 10.36 10.44 12.10 15.03 13.09 




Age Standardised Mortality Rate/ 100,000 women in South African Provinces (1997 – 2015) 
Year of Death 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Eastern Cape 0.25 0.49 0.26 0.29 0.64 0.44 0.59 0.68 0.62 0.45 0.48 0.56 0.83 0.77 0.63 0.49 0.99 1.05 1.03 
Free State 1.22 1.18 0.79 0.49 1.03 1.11 1.38 1.54 1.28 1.42 0.84 1.33 1.38 1.79 1.55 0.72 1.69 1.85 1.70 
Gauteng 1.04 1.09 0.81 0.73 1.24 0.69 1.20 1.48 1.28 1.64 1.40 1.33 1.70 1.64 1.45 1.28 1.44 1.38 1.68 
KwaZulu-Natal 0.33 0.43 0.21 0.35 0.41 0.66 0.32 0.87 0.50 1.19 0.57 0.85 0.80 0.76 0.80 0.98 1.27 1.14 1.20 
Limpopo 0.25 0.34 0.64 0.42 0.58 0.21 0.42 0.52 0.42 0.54 0.56 0.70 0.65 0.54 0.62 0.50 0.69 1.25 0.69 
Mpumalanga 0.07 0.52 0.73 0.58 0.55 0.75 0.83 1.08 0.29 0.64 0.57 1.19 0.95 0.48 1.17 0.58 0.57 0.96 0.89 
Northern Cape 1.33 2.48 3.56 1.30 1.68 1.37 1.26 1.85 1.21 0.94 1.20 0.69 1.85 1.10 1.12 1.67 1.37 2.10 1.96 
North West 0.10 0.49 0.66 0.64 0.23 0.62 0.38 0.50 0.63 0.56 0.44 0.61 0.76 0.46 1.08 0.73 0.64 1.77 1.14 









Age at death 
P-Value 
< 50 years 
N= 266 (%) 
≥ 50 years 
N= 3261 (%) 
Western Cape 39 (6.57) 555 (93.43) 
0.02 
Eastern Cape 29 (7.63) 351 (92.37) 
Northern Cape 13 (9.42) 125 (90.58) 
Free State 29 (9.67) 271 (90.33) 
Kwazulu Natal 42 (7.42) 524 (92.58) 
North West 21 (11.73) 158 (88.27) 
Gauteng 55 (5.76) 900 (94.24) 
Mpumalanga 21 (12.35) 149 (87.65) 





Mortality Incidence Rate of EC in South Africa 1997-2014 
 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
All 0.28 0.30 0.26 0.22 0.22 0.21 0.24 0.24 0.20 0.28 0.25 0.26 0.28 0.27 0.26 0.22 0.30 0.29 
Black 0.10 0.17 0.20 0.23 0.23 0.21 0.25 0.24 0.20 0.27 0.18 0.24 0.24 0.23 0.27 0.24 0.34 0.33 
Coloured 0.00 0.10 0.39 0.16 0.16 0.14 0.21 0.11 0.19 0.23 0.23 0.19 0.34 0.26 0.28 0.26 0.49 0.26 
Indian/Asian 0.00 0.00 0.38 0.07 0.09 0.25 0.08 0.26 0.15 0.24 0.20 0.07 0.17 0.10 0.15 0.08 0.14 0.14 
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